reactive arthritis: Reactive arthritis (ReA) is an autoimmune disorder belonging to the group of seronegative spondyloarthropathies and is characterized by the classic triad of arthritis, urethritis and conjunctivitis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3016 |
6. Filter based on genotype QC (FinnGen only) |
3016 |
Control definitions (FinnGen only)
- Control exclude
- RHEUMA_ENDPOINTS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Reactive arthropathies, FINNGEN
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 21080 | 10192 | 10784 |
| Only index persons | 19480 | 9565 | 9915 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.30 | 0.29 | 0.30 |
| Only index persons | 0.37 | 0.35 | 0.38 |
| Median age at first event (years) | |||
| Whole population | 44.48 | 45.08 | 43.82 |
| Only index persons | 43.96 | 44.60 | 43.34 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3016 | 1700 | 1316 |
| Unadjusted period prevalence (%) | 0.58 | 0.58 | 0.58 |
| Median age at first event (years) | 46.60 | 44.23 | 49.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2702
- Matched controls
- 27019
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2702.9
323.0
2004
27
P01BA02
ATC
hydroxychloroquine; oral
40.0
323.0
569
179
M02.1
ICD-10 Finland
Postdysenteric arthropathy
1917.3
323.0
326
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
64.1
323.0
694
145
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
97.0
323.0
1057
178
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
53.9
323.0
648
157
M02.8
ICD-10 Finland
Other reactive arthropathies
690.7
323.0
412
7
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
50.3
323.0
808
227
A07EC01
ATC
sulfasalazine; oral, rectal
86.1
323.0
1029
192
M13.9
ICD-10 Finland
Arthritis, unspecified
62.6
323.0
854
198
H02AB06
ATC
prednisolone; systemic
5.8
323.0
1847
7303
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
139.0
301.9
319
26
M17.1
ICD-10 Finland
Other primary gonarthrosis
15.3
273.9
474
371
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
415.8
268.2
265
7
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
364.4
267.8
266
8
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
560.0
260.6
255
5
L88
ICPC
Rheumatoid/seropositive arthritis
130.3
253.6
270
23
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
219.8
208
*
M02.3
ICD-10 Finland
Reiter disease
+∞
209.1
198
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
725.3
207.4
202
*
M45
ICD-10 Finland
Ankylosing spondylitis
186.6
199.9
207
12
L04AA13
ATC
leflunomide; oral
513.7
195.1
192
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
9.8
185.0
398
470
M25.5
ICD-10 Finland
Pain in joint
3.7
178.3
1014
3775
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
52.6
139.7
168
34
H02AB07
ATC
prednisone; oral
4.3
138.9
588
1633
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
10.8
136.2
273
277
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
56.2
133.8
159
30
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
1341.9
132.4
128
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
343.4
131.8
132
*
TNG10
NOMESCO Finland
Puncture of knee
280.3
131.4
133
5
L04AB01
ATC
etanercept; parenteral
202.8
130.9
135
7
M16.1
ICD-10 Finland
Other primary coxarthrosis
24.5
127.2
183
80
M01AH05
ATC
etoricoxib; oral
2.6
116.9
1683
10584
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
108.8
1213
6533
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
39.2
108.5
138
37
M13.0
ICD-10 Finland
Polyarthritis, unspecified
75.6
108.4
123
17
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
108.3
900
4080
A02BC02
ATC
pantoprazole; systemic
2.5
106.7
1785
11878
L04AB04
ATC
adalimumab; parenteral
30.7
106.2
143
49
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
123.7
99.7
107
9
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
5.1
98.4
335
726
N02AX02
ATC
tramadol; systemic, rectal
2.4
92.1
1144
6352
M01AH01
ATC
celecoxib; oral (coxibs)
3.3
91.7
545
1942
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
7.5
90.2
224
322
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.7
83.7
310
730
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
93.1
81.5
90
10
M10.9
ICD-10 Finland
Gout, unspecified
8.3
80.4
186
239
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
22.4
80.3
118
55
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
22.0
79.8
118
56
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
275.5
78.9
80
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
69.8
76.8
88
13
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
260.7
74.8
76
*
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
44.2
72.8
90
21
J01MA02
ATC
ciprofloxacin; systemic
2.2
72.4
1078
6311
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
22.7
71.9
105
48
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
716.7
71.4
70
*
R4110
NOMESCO Finland
Physiotherapy
2.4
69.7
760
3827
M01AC06
ATC
meloxicam; systemic, rectal
2.2
69.5
971
5498
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
6.5
67.7
185
303
XX9XE
NOMESCO Finland
Other ultrasound examination
54.9
67.3
80
15
NF1AA
NOMESCO Finland
Hip X-ray examination
5.8
67.1
200
366
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
22.8
66.6
97
44
M01CB01
ATC
sodium aurothiomalate; parenteral
329.8
64.7
65
*
M01AE02
ATC
naproxen; oral, rectal
2.0
64.5
1552
10891
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
72.7
62.4
71
10
L15
ICPC
Knee symptom/complaint
2.7
61.4
497
2110
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
39.6
61.0
77
20
M35.3
ICD-10 Finland
Polymyalgia rheumatica
13.7
60.9
107
81
B01AB05
ATC
enoxaparin; parenteral
2.3
60.4
711
3671
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
59.6
57
*
L04AB06
ATC
golimumab; parenteral
69.6
59.4
68
10
M07.3
ICD-10 Finland
Other psoriatic arthropathies
204.4
58.3
60
*
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
16.8
57.6
93
57
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
4.4
57.4
221
535
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
57.3
1180
7667
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
57.2
56.9
67
12
M79.6
ICD-10 Finland
Pain in limb
2.0
55.8
898
5287
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
55.5
969
5889
M04AA01
ATC
allopurinol; systemic
3.3
54.9
299
974
J01DB01
ATC
cefalexin; oral
2.1
53.3
2174
17947
WX111
NOMESCO Finland
Local infiltration anesthesia
142.9
53.0
56
*
WX320
NOMESCO Finland
Spinalanesthesy
2.4
52.2
518
2437
R50.9
ICD-10 Finland
Fever, unspecified
2.6
50.7
428
1844
N02BE01
ATC
paracetamol; systemic, rectal
2.1
50.0
2212
18526
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
12.4
49.6
91
76
212
Kela drug reimbursment
Gout
+∞
49.1
47
*
ZXA00
NOMESCO Finland
Right side
2.1
48.0
648
3503
M01AH02
ATC
rofecoxib; oral
2.8
47.8
338
1310
NG1DA
NOMESCO Finland
X-ray of knees
28.5
47.0
64
23
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
56.1
46.6
55
10
M13.8
ICD-10 Finland
Other specified arthritis
24.1
46.3
66
28
L20
ICPC
Joint symptom/complaint NOS
5.7
46.0
137
250
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
101.9
45.9
50
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
45.1
299
1109
J01FF01
ATC
clindamycin; systemic
2.0
44.9
716
4123
M01AB05
ATC
diclofenac; systemic, rectal
1.8
44.8
1720
13359
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
36.4
44.5
57
16
M10.0
ICD-10 Finland
Idiopathic gout
10.0
43.2
88
91
7138X
ICD-9 Finland
Arthropathy associated with other disorders classified elsewhere, Arthropathy associated with other conditions classifiable elsewhere
+∞
42.8
41
*
M01AX05
ATC
glucosamine; oral
2.6
42.8
356
1513
ZX140
NOMESCO Finland
Intra articular
51.9
42.7
51
10
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.4
41.8
114
186
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
41.1
244
840
L04AX01
ATC
azathioprine; systemic
4.4
39.6
149
352
ZXA05
NOMESCO Finland
Left side
2.0
39.5
588
3273
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
39.5
693
4105
WX002
NOMESCO Finland
Sedation and analgesia
2.2
39.4
474
2411
M01AX17
ATC
nimesulide; oral
2.0
39.1
581
3230
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
38.8
279
1087
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.2
38.5
153
381
L04AB05
ATC
certolizumab pegol; parenteral
382.6
38.1
38
*
M01CB03
ATC
auranofin; oral
+∞
37.6
36
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
3.0
37.6
236
843
J01FA06
ATC
roxithromycin; oral
1.7
37.4
1036
7121
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
37.3
999
6796
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
19.7
37.0
56
29
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
28.3
36.9
50
18
A46
ICD-10 Finland
Erysipelas
2.4
36.7
340
1522
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
36.5
35
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.2
35.9
197
640
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
35.8
243
911
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
59.4
35.2
41
7
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
67.5
35.0
40
6
H02AB04
ATC
methylprednisolone; systemic
2.3
34.9
368
1757
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
34.8
912
6128
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.4
34.1
129
306
NH3EA
NOMESCO Finland
Feet X-ray examination with load
11.9
34.1
63
54
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
4.3
33.1
128
311
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
32.5
451
2421
M01AB01
ATC
indometacin; systemic, rectal
3.0
32.2
192
662
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
6.1
31.7
88
148
J01FA10
ATC
azithromycin; systemic
1.6
31.5
1500
11785
J01AA02
ATC
doxycycline; systemic
1.7
31.3
1964
16588
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
23.5
30.9
44
19
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.8
30.6
216
827
N03AX16
ATC
pregabalin; oral
1.9
30.6
529
3078
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
24.2
30.5
43
18
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
52.1
30.3
36
7
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
+∞
30.3
29
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
29.6
240
995
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
29.3
165
545
M03BX02
ATC
tizanidine; oral
1.6
29.0
1561
12521
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
81.0
28.8
32
*
A02BC01
ATC
omeprazole; systemic
1.8
28.8
635
3999
H20.1
ICD-10 Finland
Chronic iridocyclitis
9.5
28.6
59
63
J01DA01
ATC
[U] cefalexin; systemic
1.6
28.6
1577
12703
M02AA07
ATC
piroxicam; topical
1.7
28.3
809
5500
A02BC05
ATC
esomeprazole; systemic
1.6
28.0
940
6673
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
27.9
500
2937
R4120
NOMESCO Finland
Occupational therapy
2.9
27.6
176
634
M35.7
ICD-10 Finland
Hypermobility syndrome
23.3
27.4
39
17
M01AB55
ATC
diclofenac, combinations; oral
3.0
27.4
167
583
ZX120
NOMESCO Finland
Intravenous
2.4
27.3
249
1101
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
27.3
860
5994
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
26.9
444
2531
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
26.8
501
2979
J01CA04
ATC
amoxicillin; systemic
1.6
26.7
2064
17926
L04AA11
ATC
[U] etanercept; parenteral
141.4
26.7
28
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
26.6
2339
21081
Z50.1
ICD-10 Finland
Other physical therapy
3.2
26.5
148
487
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
26.5
326
1655
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
60.6
26.0
30
5
J01MA12
ATC
levofloxacin; systemic
1.9
25.7
426
2425
M66.0
ICD-10 Finland
Rupture of popliteal cyst
9.5
25.7
53
57
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
25.4
896
6403
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
25.2
511
3117
M79.7
ICD-10 Finland
Fibromyalgia
5.4
25.1
76
143
M09AX01
ATC
hyaluronic acid; parenteral
5.2
25.0
79
156
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
25.0
159
571
UJF32
NOMESCO Finland
Coloscopy
1.7
24.9
566
3576
L17
ICPC
Foot/toe symptom/complaint
1.7
24.8
561
3539
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.4
24.5
220
963
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
16.5
24.5
39
24
M25.4
ICD-10 Finland
Effusion of joint
9.8
24.2
49
51
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.0
24.0
67
114
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
+∞
24.0
23
*
M17.5
ICD-10 Finland
Other secondary gonarthrosis
25.7
23.9
33
13
M02
ICD-10 Finland
Reactive arthropathies
68.0
23.8
27
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.7
23.8
175
686
L04AA01
ATC
[U] ciclosporin; systemic
8.0
23.7
54
69
L90
ICPC
Osteoarthrosis of knee
4.4
23.6
87
203
B01AX06
ATC
[U] rivaroxaban; oral
18.2
23.5
36
20
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
8.3
23.4
52
64
N03AX12
ATC
gabapentin; oral
2.0
22.9
333
1804
S01FA04
ATC
cyclopentolate; ophthalmic
7.9
22.7
52
67
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
4.9
22.6
75
157
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
22.3
365
2065
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
21.9
190
817
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
6.0
21.9
61
104
M02.0
ICD-10 Finland
Arthropathy following intestinal bypass
+∞
21.9
21
*
A02BC03
ATC
lansoprazole; oral
1.6
21.8
648
4395
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
21.7
1090
8375
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.6
21.5
100
287
M01AC01
ATC
piroxicam; systemic, rectal
2.0
21.5
307
1650
B01AF01
ATC
rivaroxaban; oral
2.5
21.4
175
729
L04AD01
ATC
ciclosporin; systemic
5.3
21.3
66
128
WZA90
NOMESCO Finland
Other doctors statement
1.7
21.3
521
3346
M05BA04
ATC
alendronic acid; oral
2.6
21.3
158
625
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
23.3
21.3
30
13
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
50.4
21.1
25
5
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
6.8
21.1
53
79
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
21.0
385
2259
M03.2*A04.6
ICD-10 Finland
Postinfectious arthropathy in enteritis due to Yersinia enterocolitica
+∞
20.9
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
20.7
635
4331
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
20.5
482
3057
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.3
20.4
77
184
WZA10
NOMESCO Finland
Long statement of health and health related matters
7.7
20.3
47
62
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
5.3
20.3
62
119
NG2AA
NOMESCO Finland
Patella X-ray examination
9.4
20.1
41
44
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
3.2
19.8
106
340
L04AA24
ATC
abatacept; parenteral
+∞
19.8
19
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
19.8
19
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
19.8
252
1294
S18
ICPC
Laceration/cut
1.5
19.8
879
6539
R06.0
ICD-10 Finland
Dyspnoea
1.7
19.8
493
3178
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
19.7
120
420
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
19.7
366
2155
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
74.0
19.7
22
*
SPAT1202
SPAT
Intra-articular injection
4.9
19.6
64
132
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
5.4
19.6
59
111
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
105.8
19.6
21
*
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
105.8
19.6
21
*
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
201.4
19.6
20
*
A02BA02
ATC
ranitidine; systemic
1.7
19.3
415
2558
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
19.2
340
1970
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.3
19.2
178
793
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
20.2
19.0
28
14
M11.2
ICD-10 Finland
Other chondrocalcinosis
55.4
18.9
22
*
L04AA17
ATC
[U] adalimumab; parenteral
+∞
18.8
18
*
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
70.4
18.7
21
*
J02AC01
ATC
fluconazole; systemic
1.5
18.5
941
7178
S01FA02
ATC
scopolamine; ophthalmic
7.7
18.3
42
55
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
18.3
545
3676
L04AC10
ATC
secukinumab; parenteral
25.2
18.2
25
10
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
21.9
18.2
26
12
NF1DA
NOMESCO Finland
X-ray of hips
9.4
18.1
37
40
R53
ICD-10 Finland
Malaise and fatigue
1.7
17.8
446
2870
P01AB01
ATC
metronidazole; oral, rectal
1.5
17.8
917
7000
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
3.2
17.8
94
300
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.4
17.7
85
252
C03CA01
ATC
furosemide; systemic
1.6
17.5
477
3136
1220
FHL
Arthroscopy
3.1
17.5
96
314
13603
ICD-8 Finland
Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis
181.1
17.5
18
*
ZXA10
NOMESCO Finland
Bilateral
1.7
17.4
387
2405
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
17.3
255
1385
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
17.2
236
1247
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
17.1
358
2181
L13
ICPC
Hip symptom/complaint
1.9
17.1
251
1357
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
17.1
221
1139
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
17.0
357
2179
M06
ICD-10 Finland
Other rheumatoid arthritis
50.3
17.0
20
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.8
16.8
56
119
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
5.4
16.8
50
94
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
16.7
380
2373
B01AB04
ATC
dalteparin; parenteral
2.9
16.7
106
380
N02AA05
ATC
oxycodone; systemic
1.9
16.7
260
1439
M01AX01
ATC
nabumetone; oral
3.0
16.7
98
336
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
+∞
16.7
16
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
16.7
16
*
L28
ICPC
Limited function/disability (L)
1.9
16.6
264
1470
R03AC02
ATC
salbutamol; inhalant
1.4
16.6
1210
9844
Z71.8
ICD-10 Finland
Other specified counselling
1.6
16.4
538
3703
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
16.3
523
3577
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.2
16.3
50
97
M16.7
ICD-10 Finland
Other secondary coxarthrosis
40.3
16.3
20
5
A01
ICPC
Pain general/multiple sites
2.2
16.3
163
751
M54.5
ICD-10 Finland
Low back pain
1.5
16.3
720
5302
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
16.2
217
1136
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
16.2
1225
10013
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
16.2
204
1042
E0000UV
ATC
NA
1.4
16.2
874
6704
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
30.2
16.1
21
7
NGS10
NOMESCO Finland
Incision and debridement of infection of knee joint
47.8
16.0
19
*
J01FA09
ATC
clarithromycin; systemic
1.5
15.9
742
5523
N06AA09
ATC
amitriptyline; systemic
2.0
15.7
202
1038
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
15.6
15
*
291
Kela drug reimbursment
Tofacitinib
+∞
15.6
15
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
17.3
15.6
24
14
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
15.5
268
1537
R01AD09
ATC
mometasone; nasal
1.4
15.5
1061
8498
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.8
15.3
64
170
M19.8
ICD-10 Finland
Other specified arthrosis
3.3
15.2
76
234
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
15.0
270
1570
R60.0
ICD-10 Finland
Localized oedema
2.0
14.7
205
1091
WX110
NOMESCO Finland
Local anesthesy
1.4
14.7
1662
14473
J01MA14
ATC
moxifloxacin; systemic
2.0
14.6
198
1040
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
+∞
14.6
14
*
C08CA01
ATC
amlodipine; oral
1.5
14.6
669
4947
M03.2
ICD-10 Finland
Other postinfectious arthropathies in diseases classified elsewhere
80.5
14.6
16
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
14.6
494
3421
D05AX52
ATC
calcipotriol, combinations; topical
2.4
14.5
126
545
R51.80
ICD-10 Finland
Headache
1.7
14.5
324
2010
L04AA29
ATC
tofacitinib; oral
36.2
14.4
18
5
M19.9
ICD-10 Finland
Arthrosis, unspecified
3.3
14.4
73
227
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
14.3
682
5077
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
14.2
96
360
L89
ICPC
Osteoarthrosis of hip
6.8
14.2
35
52
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
5.3
14.0
42
80
D07AC01
ATC
betamethasone; topical
1.4
14.0
731
5538
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.8
13.9
46
98
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
30.2
13.9
18
6
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
13.9
208
1135
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.3
13.8
132
598
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
13.7
292
1786
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
13.6
377
2478
R05
ICD-10 Finland
Cough
1.6
13.6
396
2638
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.5
13.6
62
178
C07AB07
ATC
bisoprolol; oral
1.4
13.6
918
7283
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
12.1
13.6
24
20
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
4.2
13.5
51
124
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
13.5
13
*
L04AC07
ATC
tocilizumab; parenteral
+∞
13.5
13
*
R42
ICD-10 Finland
Dizziness and giddiness
1.6
13.5
419
2832
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
5.8
13.4
37
64
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
13.4
643
4784
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
13.4
66
202
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
4.5
13.2
46
104
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
13.2
529
3793
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
13.2
119
525
1221
FHL
Arthroscopy and meniscus surgery
3.6
13.1
58
163
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
13.1
1711
15100
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
13.0
203
1120
M25.9
ICD-10 Finland
Joint disorder, unspecified
6.2
13.0
34
55
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
13.0
369
2441
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
12.9
880
6976
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
22.6
12.9
18
8
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
12.9
198
1091
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.5
12.9
99
402
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
12.8
300
1884
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
12.8
86
324
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
12.8
160
816
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
4.9
12.8
41
85
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
12.8
1536
13345
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
12.7
449
3129
J05AB11
ATC
valaciclovir; oral
1.7
12.7
278
1716
R06AE07
ATC
cetirizine; oral
1.4
12.6
1005
8172
4AB02
NOMESCO Finland
NA
12.3
12.6
22
18
7130A
ICD-9 Finland
Arthropathy associated with other disorders classified elsewhere, Arthropathy associated withother endocrine and metabolic disorders
+∞
12.5
12
*
0993A
ICD-9 Finland
Other venereal diseases, Reiter's disease
+∞
12.5
12
*
71498
ICD-8 Finland
Other specified forms of arthritis, Alia definita
+∞
12.5
12
*
PAW37
NOMESCO Finland
Biopsy of temporal artery
17.4
12.5
19
11
RT272
NOMESCO Finland
NA
20.1
12.4
18
9
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
12.4
1293
10966
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
12.3
484
3453
M79.1
ICD-10 Finland
Myalgia
1.7
12.3
261
1594
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
12.2
1120
9303
RT271
NOMESCO Finland
NA
37.7
12.2
15
*
1222
FHL
Arthroscopy and synovial surgery
6.7
12.2
30
45
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
12.1
330
2155
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
26.8
12.0
16
6
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.8
12.0
49
129
M10
ICD-10 Finland
Gout
2.8
11.9
76
278
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
46.9
11.9
14
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
11.7
11.8
21
18
M48.0
ICD-10 Finland
Spinal stenosis
1.9
11.8
183
1010
H02AB08
ATC
triamcinolone; systemic
16.5
11.7
18
11
7118L
ICD-9 Finland
Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, USEAT NIVELET]
30.1
11.6
15
5
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
11.6
277
1750
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
11.6
154
804
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.2
11.6
121
573
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
11.5
146
749
B34.9
ICD-10 Finland
Viral infection, unspecified
2.7
11.5
76
283
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
11.5
574
4287
J20
ICD-10 Finland
Acute bronchitis
1.8
11.5
194
1103
7113L
ICD-9 Finland
Arthropathy associated with infections, Postdysenteric arthropathy[ENTEROARTHRITIS, USEAT NIVELET]
+∞
11.5
11
*
7111L
ICD-9 Finland
Arthropathy associated with infections, Arthropathy associated with Reiter's disease and nonspecific urethritis[UROARTHRITIS, USEAT NIVELET]
+∞
11.5
11
*
7131A
ICD-9 Finland
Arthropathy associated with other disorders classified elsewhere, Arthropathy associated with gastro-intestinal conditions other than infections
+∞
11.5
11
*
M12.3
ICD-10 Finland
Palindromic rheumatism
120.5
11.4
12
*
M01AB08
ATC
etodolac; oral
2.0
11.4
149
773
D07AC13
ATC
mometasone; topical
1.4
11.4
616
4669
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.2
11.3
119
564
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
11.3
208
1216
N06AX21
ATC
duloxetine; oral
1.8
11.3
215
1271
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
11.3
59
190
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
11.2
1692
15067
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.9
11.1
67
237
3005
Kela drug reimbursment
Tofacitinib
25.1
11.1
15
6
NDG30
NOMESCO Finland
Fusion of wrist, total
20.1
11.1
16
8
A03
ICPC
Fever
1.5
11.0
359
2448
A02.0
ICD-10 Finland
Salmonella enteritis
8.6
11.0
23
27
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
11.0
110
511
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
11.0
81
323
J01MA06
ATC
norfloxacin; oral
1.6
11.0
280
1798
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
11.0
148
780
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.6
10.9
27
41
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
10.9
474
3441
NH3AE
NOMESCO Finland
Feet ultrasound examination
43.5
10.9
13
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
10.9
96
421
UKC02
NOMESCO Finland
Cystoscopy
1.6
10.8
296
1937
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
4.2
10.7
39
93
288
Kela drug reimbursment
Febuxostat
28.1
10.7
14
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
10.7
511
3782
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
60.2
10.6
12
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
10.6
1350
11682
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
10.6
331
2237
L08
ICPC
Shoulder symptom/complaint
1.5
10.6
358
2464
G47.3
ICD-10 Finland
Sleep apnoea
1.5
10.6
428
3062
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.5
445
3209
L03
ICPC
Low back symptom/complaint
1.4
10.5
474
3463
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
10.5
136
704
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
10.5
142
750
Z01.7
ICD-10 Finland
Laboratory examination
1.7
10.5
234
1451
M08.2
ICD-10 Finland
Juvenile arthritis with systemic onset
110.4
10.4
11
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
110.4
10.4
11
*
7169X
ICD-9 Finland
Other and unspecified arthropathies, Arthropathy, unspecified
+∞
10.4
10
*
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
+∞
10.4
10
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
10.4
10
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
10.4
10
*
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
+∞
10.4
10
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
10.4
10
*
7166A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified monoarthritis
+∞
10.4
10
*
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
+∞
10.4
10
*
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
10.4
10
*
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
+∞
10.4
10
*
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
10.4
87
372
A07EC02
ATC
mesalazine; oral, rectal
2.0
10.3
126
638
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.6
10.3
76
301
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.3
169
953
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
18.8
10.3
15
8
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
10.2
197
1168
L12
ICPC
Hand/finger symptom/complaint
1.6
10.2
283
1857
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
10.2
176
1011
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
10.1
184
1072
R52.9
ICD-10 Finland
Pain, unspecified
1.8
10.1
173
990
L16
ICPC
Ankle symptom/complaint
1.7
10.1
194
1154
K02.1
ICD-10 Finland
Caries of dentine
1.3
10.0
1331
11547
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
10.0
146
789
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
10.0
167
949
M77.9
ICD-10 Finland
Enthesopathy, unspecified
2.8
10.0
63
230
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
40.2
10.0
12
*
L52
ICD-10 Finland
Erythema nodosum
5.8
9.9
27
47
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
9.9
157
875
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.8
9.9
63
231
B01AA03
ATC
warfarin; systemic
1.5
9.9
312
2112
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.8
9.9
63
232
XQ800
NOMESCO Finland
Prick test
1.8
9.9
169
967
XKD00
NOMESCO Finland
Uroflowmetry
1.6
9.9
285
1891
R2110
NOMESCO Finland
Giving the first information
1.8
9.8
154
856
UJH02
NOMESCO Finland
Anoscopy
2.2
9.8
92
417
M19.2
ICD-10 Finland
Other secondary arthrosis
5.4
9.8
28
52
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
9.8
251
1616
NDL52
NOMESCO Finland
Tenosynovectomy of hand
10.6
9.8
18
17
N05CF01
ATC
zopiclone; oral
1.4
9.7
643
5027
M54.2
ICD-10 Finland
Cervicalgia
1.9
9.7
149
821
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
9.7
143
776
A07AA02
ATC
nystatin; oral
2.0
9.6
118
597
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
9.6
385
2745
K07.60
ICD-10 Finland
Snapping jaw
2.1
9.6
109
535
R04.0
ICD-10 Finland
Epistaxis
1.9
9.5
128
674
H15.1
ICD-10 Finland
Episcleritis
3.6
9.5
41
115
C01CA24
ATC
epinephrine; parenteral
1.9
9.5
138
749
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
9.4
110
546
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
100.4
9.4
10
*
M04AA03
ATC
febuxostat; oral
30.1
9.4
12
*
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
17.6
9.4
14
8
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
+∞
9.4
9
*
L01CB
ATC
Podophyllotoxin derivatives
+∞
9.4
9
*
3006
Kela drug reimbursment
Baricitinib
+∞
9.4
9
*
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
+∞
9.4
9
*
293
Kela drug reimbursment
Baricitinib
+∞
9.4
9
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
9.4
212
1319
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.3
9.3
27
51
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
4.4
9.3
32
73
M76.6
ICD-10 Finland
Achilles tendinitis
2.2
9.3
96
455
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
9.3
447
3304
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
9.3
232
1485
R02
ICPC
Shortness of breath/dyspnoea
1.6
9.2
222
1404
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
9.1
53
184
R74
ICPC
Upper respiratory infection acute
1.4
9.1
636
5011
M02AA10
ATC
ketoprofen; topical
1.5
9.1
302
2069
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
15.6
9.0
14
9
K50.8
ICD-10 Finland
Other Crohn disease
3.3
9.0
43
131
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
36.8
9.0
11
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.8
9.0
36
95
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
9.0
253
1666
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
4.9
9.0
28
58
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
9.0
132
720
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
9.0
663
5268
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.5
8.9
65
259
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
1.8
8.9
143
802
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
8.9
188
1147
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
24.1
8.9
12
5
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
8.9
159
924
E000001
ATC
NA
1.4
8.9
426
3143
J01CF02
ATC
cloxacillin; systemic
3.0
8.9
49
166
SPAT1153
SPAT
Removal of sutures
1.4
8.9
597
4675
RJ411
NOMESCO Finland
NA
8.0
8.8
19
24
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
6.8
8.8
21
31
JN4BD
NOMESCO Finland
Extensive body CT
1.6
8.8
213
1352
J01FA01
ATC
erythromycin; systemic
1.5
8.8
309
2142
M23.4
ICD-10 Finland
Loose body in knee
8.6
8.8
18
21
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
8.8
699
5614
G44.2
ICD-10 Finland
Tension-type headache
1.6
8.8
261
1741
H57.1
ICD-10 Finland
Ocular pain
2.4
8.8
70
293
T92
ICPC
Gout
4.0
8.7
33
83
J05AB01
ATC
aciclovir; systemic
1.4
8.7
424
3138
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.9
8.7
50
172
C09CA01
ATC
losartan; oral
1.4
8.7
435
3234
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.0
8.7
105
532
349
Kela drug reimbursment
Febuxostat
50.1
8.7
10
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
8.7
1095
9376
1225
FHL
Arthroscopy and other therapeutic procedure
4.1
8.6
32
79
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.1
8.6
95
461
S97
ICPC
Chronic ulcer skin
2.2
8.6
88
414
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
6.2
8.6
22
36
R03AC03
ATC
terbutaline; inhalant
1.5
8.5
286
1961
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
27.6
8.5
11
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
8.5
108
560
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.8
8.4
133
742
SPAT1204
SPAT
Arthrocentesis
6.0
8.4
22
37
A28
ICPC
Limited function/disability NOS
1.6
8.4
217
1399
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
8.4
554
4316
7168A
ICD-9 Finland
Other and unspecified arthropathies, Other specified arthropathy
90.3
8.4
9
*
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.2
8.4
42
133
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
8.4
98
487
H02BX01
ATC
methylprednisolone, combinations; systemic
2.1
8.4
87
414
R06AX27
ATC
desloratadine; oral
1.3
8.4
591
4656
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
8.3
184
1136
NCF10
NOMESCO Finland
Synovectomy of elbow joint, open
+∞
8.3
8
*
L04AC14
ATC
sarilumab; systemic
+∞
8.3
8
*
M16.2
ICD-10 Finland
Coxarthrosis resulting from dysplasia, bilateral
+∞
8.3
8
*
M05.0
ICD-10 Finland
Felty syndrome
+∞
8.3
8
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
8.3
8
*
7118F
ICD-9 Finland
Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, POLVI]
+∞
8.3
8
*
71109
ICD-8 Finland
Acute nonpyogenic arthritis, Unspecified
+∞
8.3
8
*
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
8.3
8
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.8
8.3
148
862
X58
ICD-10 Finland
Exposure to other specified factors
1.5
8.3
273
1869
Z01.2
ICD-10 Finland
Dental examination
1.3
8.2
900
7545
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.9
8.2
32
83
ACC51
NOMESCO Finland
Release of median nerve
1.8
8.2
131
733
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
8.2
216
1400
R03BA05
ATC
fluticasone; inhalant
1.4
8.2
367
2673
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.1
8.2
30
74
M05BA07
ATC
risedronic acid; oral
2.9
8.1
47
163
R03BA02
ATC
budesonide; inhalant
1.4
8.1
353
2556
9243
FHL
Plastic of the patella and its tendons
5.4
8.1
23
43
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.3
8.1
70
307
S83.2
ICD-10 Finland
Tear of meniscus, current
1.8
8.1
125
694
M22.4
ICD-10 Finland
Chondromalacia patellae
2.5
8.1
60
243
RT171
NOMESCO Finland
NA
17.2
8.1
12
7
71599
ICD-8 Finland
Arthritis, unspecified
10.0
8.0
15
15
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
8.0
124
689
M15
ICD-10 Finland
Polyarthrosis
2.4
8.0
66
284
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
7.9
431
3251
D07AD01
ATC
clobetasol; topical
1.5
7.9
296
2080
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
7.9
849
7091
R05
ICPC
Cough
1.4
7.9
446
3383
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.6
7.9
216
1415
R35
ICD-10 Finland
Polyuria
1.9
7.9
109
581
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.3
7.8
37
113
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
7.8
135
777
J01DA06
ATC
[U] cefuroxime; systemic
1.5
7.8
300
2120
J01CF05
ATC
flucloxacillin; systemic
2.2
7.8
75
346
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
3.4
7.8
35
103
72908
ICD-8 Finland
Other diseases of joint, Alii definiti
9.4
7.8
15
16
R31
ICD-10 Finland
Unspecified haematuria
1.7
7.8
175
1088
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.7
958
8144
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
45.1
7.7
9
*
H05AA02
ATC
teriparatide; parenteral
45.1
7.7
9
*
E883A
ICD-9 Finland
Fall into hole or other opening in surface
2.0
7.7
95
486
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.7
7.7
49
181
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.6
7.7
54
213
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
3.0
7.7
41
137
S91
ICPC
Psoriasis
5.3
7.7
22
42
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
7.7
805
6700
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
7.4
7.7
17
23
L50.9
ICD-10 Finland
Urticaria, unspecified
2.2
7.7
77
363
L04AA06
ATC
mycophenolic acid; systemic
3.2
7.6
37
116
ND1AE
NOMESCO Finland
Wrist ultrasound examination
11.9
7.6
13
11
M13
ICD-10 Finland
Other arthritis
25.1
7.6
10
*
318
Kela drug reimbursment
Teriparatide
25.1
7.6
10
*
NGF10
NOMESCO Finland
Total synovectomy of knee, open
25.1
7.6
10
*
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
7.5
424
3215
L40.8
ICD-10 Finland
Other psoriasis
5.1
7.5
22
43
TAB00
NOMESCO Finland
Lumbar puncture
2.0
7.5
96
499
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.5
389
2910
J45
ICD-10 Finland
Asthma
1.6
7.5
179
1133
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
7.5
121
681
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
7.4
202
1321
C09CA06
ATC
candesartan; oral
1.4
7.4
406
3060
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
7.4
205
1346
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.7
7.4
48
180
M54
ICD-10 Finland
Dorsalgia
1.5
7.4
224
1500
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
80.3
7.4
8
*
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
6.5
7.4
18
28
L70
ICPC
Infection of musculoskeletal system
7.7
7.4
16
21
L11
ICPC
Wrist symptom/complaint
1.7
7.4
142
848
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.9
7.3
101
540
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
7.3
220
1472
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
8.4
7.3
15
18
M70.2
ICD-10 Finland
Olecranon bursitis
2.4
7.3
59
252
R5110
SPAT
NA
2.8
7.3
43
153
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
7.3
7
*
L04AA37
ATC
baricitinib; oral
+∞
7.3
7
*
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
+∞
7.3
7
*
K30
ICD-10 Finland
Functional dyspepsia
1.6
7.3
203
1336
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.6
7.3
51
201
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
7.3
268
1876
VALMI
NOMESCO Finland
NA
1.3
7.3
545
4325
WX892
NOMESCO Finland
Monitored bed care
1.7
7.2
147
890
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.4
7.2
33
99
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
7.1
329
2405
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
7.1
101
545
R52.0
ICD-10 Finland
Acute pain
2.3
7.1
62
272
KMAK
NOMESCO Finland
NA
1.2
7.1
1197
10526
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.8
7.1
125
724
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
7.1
84
423
K92.1
ICD-10 Finland
Melaena
2.0
7.1
84
423
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.2
7.1
70
327
N02AC04
ATC
dextropropoxyphene; oral
2.4
7.0
57
244
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.0
395
2995
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.2
7.0
65
296
D07XC01
ATC
betamethasone, combinations; topical
1.5
7.0
218
1470
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
10.0
7.0
13
13
J03.0
ICD-10 Finland
Streptococcal tonsillitis
2.2
7.0
67
309
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.9
7.0
98
527
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
7.0
418
3204
L99
ICPC
Musculoskeletal disease other
3.3
7.0
33
102
A69.2
ICD-10 Finland
Lyme disease
1.9
6.9
100
545
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
3.2
6.9
34
108
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.9
556
4452
N19
ICD-10 Finland
Unspecified kidney failure
2.5
6.9
52
214
-1
NOMESCO Finland
NA
1.3
6.9
728
6049
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.9
147
906
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
6.8
82
415
I45.9
ICD-10 Finland
Conduction disorder, unspecified
4.4
6.8
23
53
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.8
551
4412
L29
ICPC
Musculoskeletal sympt/complt other
1.7
6.8
123
721
B07.9
ICD-10 Finland
Verruca simplex
2.1
6.8
71
341
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
6.8
133
798
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
4.2
6.8
24
58
L01
ICPC
Neck symptom/complaint
1.5
6.8
251
1761
M23
ICD-10 Finland
Internal derangement of knee
2.7
6.8
42
156
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
3.8
6.8
26
68
NFH10
NOMESCO Finland
Reduction of dislocation of hip joint, closed
40.1
6.8
8
*
NGA10
NOMESCO Finland
Biopsy of soft tissue or joint of knee or lower leg, percutaneous
40.1
6.8
8
*
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
40.1
6.8
8
*
M10.2
ICD-10 Finland
Drug-induced gout
40.1
6.8
8
*
S73.0
ICD-10 Finland
Dislocation of hip
16.7
6.7
10
6
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.6
6.7
171
1100
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.2
6.7
33
105
M01AH03
ATC
valdecoxib; oral
1.8
6.7
116
668
R05FB02
ATC
cough suppressants and expectorants
1.3
6.7
744
6217
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.2
6.7
62
281
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
22.6
6.7
9
*
M01.2*A69.2
ICD-10 Finland
Arthritis in Lyme disease
22.6
6.7
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
6.7
114
656
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
6.7
72
351
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.7
148
919
M01AB16
ATC
aceclofenac; oral
2.2
6.7
62
283
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
6.6
81
415
R01AD08
ATC
fluticasone; nasal
1.3
6.6
602
4897
L14
ICPC
Leg/thigh symptom/complaint
1.7
6.6
126
747
S01BC03
ATC
diclofenac; ophthalmic
2.4
6.6
51
213
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
6.6
185
1219
M77.4
ICD-10 Finland
Metatarsalgia
1.8
6.6
99
548
B01AB10
ATC
tinzaparin; parenteral
1.7
6.6
117
682
D01
ICPC
Abdominal pain/cramps general
1.5
6.6
210
1427
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.6
1002
8690
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
6.6
110
631
R01AD12
ATC
fluticasone furoate; nasal
1.3
6.6
640
5258
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.9
6.6
25
65
C07AB02
ATC
metoprolol; systemic
1.4
6.5
348
2612
A01AB10
ATC
natamycin; local oral
2.2
6.5
61
278
NBF15
NOMESCO Finland
Humeroscapular synovectomy, arthroscopic
10.0
6.5
12
12
M05BA01
ATC
etidronic acid; systemic
10.0
6.5
12
12
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.3
6.5
55
239
R03DC03
ATC
montelukast; oral
1.4
6.5
321
2379
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
6.5
288
2095
C10AC01
ATC
colestyramine; oral
2.4
6.5
50
210
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
2.8
6.4
39
143
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
70.0
6.4
7
*
A02.2
ICD-10 Finland
Localized salmonella infections
70.0
6.4
7
*
L04AC03
ATC
anakinra; parenteral
70.0
6.4
7
*
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
70.0
6.4
7
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.4
1191
10546
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.4
571
4634
A08
ICPC
Swelling
2.2
6.4
61
283
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.4
209
1428
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
2.5
6.4
46
186
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.0
6.3
72
359
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
6.3
230
1606
X57
ICD-10 Finland
Unspecified privation
2.5
6.3
45
179
I49.1
ICD-10 Finland
Atrial premature depolarization
2.2
6.3
60
277
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.0
6.3
72
360
SBB10
NOMESCO Finland
Teeth copy
1.7
6.3
125
755
D06BB04
ATC
podophyllotoxin; topical
1.7
6.3
116
683
A29
ICPC
General symptom/complaint other
1.5
6.3
195
1317
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
6.3
118
701
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
11.0
6.3
11
10
WW200
NOMESCO Finland
Immunization
2.1
6.3
62
292
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
18.0
6.3
9
5
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
6.3
126
763
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
6.3
6
*
RT310
NOMESCO Finland
NA
+∞
6.3
6
*
M16.5
ICD-10 Finland
Other post-traumatic coxarthrosis
+∞
6.3
6
*
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
6.3
6
*
7192F
ICD-9 Finland
Other and unspecified disorder of joint, Villonodular synovitis[SYNOVITIS VILLONODULARIS, POLVI]
+∞
6.3
6
*
M03.6
ICD-10 Finland
Reactive arthropathy in other diseases classified elsewhere
+∞
6.3
6
*
4AB0M
NOMESCO Finland
NA
+∞
6.3
6
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
6.3
6
*
TNF10
NOMESCO Finland
Puncture of hip joint
26.7
6.2
8
*
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
3.4
6.2
28
84
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
7.0
6.2
14
20
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.3
6.2
52
228
J01MA01
ATC
ofloxacin; systemic
1.6
6.2
153
980
S22.3
ICD-10 Finland
Fracture of rib
1.7
6.2
122
735
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.3
6.2
17
488
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
6.2
93
513
S01XA18
ATC
ciclosporin; ophthalmic
6.3
6.2
15
24
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.7
6.1
125
759
D05AX02
ATC
calcipotriol; topical
2.1
6.1
68
335
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
6.1
73
372
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.9
6.1
81
428
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.5
6.1
45
185
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.1
166
1088
L05
ICPC
Flank/axilla symptom/complaint
1.8
6.1
100
569
81
HP
Angiography of the heart and coronary arteries
1.8
6.1
93
519
NB1AT
NOMESCO Finland
Puncture of shoulder with ultrasound guidance
4.7
6.1
19
41
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
12.5
6.1
10
8
A04.5
ICD-10 Finland
Campylobacter enteritis
3.9
6.1
23
60
J04AB02
ATC
rifampicin; systemic
3.9
6.1
23
60
M01AE52
ATC
naproxen and esomeprazole; oral
2.2
6.1
58
269
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.3
6.1
50
217
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1059
3208
4.55
319.46
1.4
1.2
iu/ml
26.3
17.7
2.01
361
879
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
230
52
47.80
307.65
1.8
1.1
%
60.7
63.8
0.16
175
21
(3021788) Differential panel - Synovial fluid
347
87
44.94
307.65
1.7
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
291
99
32.43
307.65
1.6
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
477
174
32.38
307.65
1.6
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
453
131
40.52
307.65
1.9
1.3
e6/l
16932.7
11426.3
0.68
349
92
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1045
2977
4.84
307.65
1.4
1.2
u/ml
9.4
2.5
3.31
388
1205
(3036071) Salmonella sp Ab [Titer] in Serum
179
40
47.51
305.43
1.2
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
183
56
34.72
287.88
1.5
1.1
e6/l
7074.1
34549.5
0.69
132
39
(3037522) Nuclear Ab [Titer] in Serum
873
2518
4.47
276.41
1.5
1.3
titre
442.2
373.6
0.60
200
429
(3008898) HLA-B27 [Presence]
425
644
7.52
273.75
1.1
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2061
10857
3.84
263.20
10.3
5.0
e9/l
0.0
0.0
0.62
1882
9280
(3001604) Monocytes [#/volume] in Blood
2054
10814
3.82
262.12
10.2
5.0
e9/l
0.6
0.6
3.56
1877
9258
(3013115) Eosinophils [#/volume] in Blood
2096
11288
3.81
255.75
10.5
5.2
e9/l
0.2
0.2
1.52
1929
9842
(3019198) Lymphocytes [#/volume] in Blood
2079
11211
3.75
251.46
10.3
5.0
e9/l
1.9
2.0
0.27
1921
9815
(42870588) Differential panel, method unspecified - Blood
1550
6982
3.51
249.90
9.4
5.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1915
9842
3.59
249.19
10.6
5.2
%
0.7
0.7
0.33
1846
9149
(3006504) Eosinophils/100 leukocytes in Blood
1954
10174
3.61
248.90
10.6
5.1
%
2.7
2.9
2.24
1880
9434
(3019069) Monocytes/100 leukocytes in Blood
1960
10255
3.60
247.05
10.9
5.4
%
8.6
8.5
0.55
1890
9579
(3018010) Neutrophils/100 leukocytes in Blood
1964
10468
3.51
236.34
10.4
5.0
%
57.0
56.7
0.73
1889
9763
(3002030) Lymphocytes/100 leukocytes in Blood
1982
10626
3.52
236.16
10.7
5.2
%
28.3
28.6
0.49
1906
9881
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
153
57
28.22
225.71
1.8
1.1
%
30.3
25.0
0.48
119
29
(3013650) Neutrophils [#/volume] in Blood by Automated count
2193
12855
3.59
218.83
13.0
8.6
e9/l
4.1
4.0
0.38
1997
11116
(3013707) Erythrocyte sedimentation rate by Westergren method
2500
16471
4.03
195.79
7.5
2.9
mm/h
13.1
10.6
14.59
2414
15138
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
291
430
7.38
190.08
1.5
1.6
iu/ml
0.2
0.7
0.53
69
79
(3026493) Urate [Moles/volume] in Serum or Plasma
1190
5267
3.08
184.97
2.7
2.4
umol/l
4508.2
5559.7
0.38
1050
4643
(3042936) Bacteria identified in Isolate by Culture
737
2735
3.24
151.23
2.2
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2272
15411
2.92
141.77
6.1
3.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
101
47
22.20
136.61
2.2
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1666
10032
2.48
127.23
13.5
8.1
e9/l
0.0
0.0
0.28
1434
8053
(40758558) Short blood count panel - Blood
1115
5622
2.56
124.83
9.5
6.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2398
17400
2.85
119.03
10.7
6.9
u/l
76.7
77.7
0.51
2334
16323
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
441
1459
3.37
106.62
2.3
2.3
au/ml
26.3
23.3
0.21
28
105
(3035350) Ketones [Presence] in Urine by Test strip
1694
10830
2.29
105.23
4.4
3.0
estimate
0.0
0.0
0.50
296
1916
(3018095) Leukocytes [#/volume] in Urine
1317
7600
2.30
104.56
4.6
3.3
e6/l
39.5
105.8
4.41
891
5291
(3021601) Nitrite [Presence] in Urine by Test strip
1693
10842
2.28
104.45
6.2
4.2
estimate
0.0
0.0
0.80
307
1965
(3009261) Glucose [Presence] in Urine by Test strip
1705
10971
2.27
103.70
4.5
3.1
estimate
0.0
0.0
0.05
292
1887
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
409
1336
3.38
100.65
1.3
1.3
au/ml
25.1
45.6
1.50
13
67
(3023368) Bacteria identified in Blood by Culture
1023
5418
2.34
98.07
5.1
4.2
—
—
—
0
0
(3015736) pH of Urine
1390
8360
2.23
98.04
3.9
2.9
—
5.9
—
0
7
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
52
13
40.68
85.58
1.6
1.1
%
30.1
28.8
—
35
6
(3009445) Proteinase 3 Ab [Units/volume] in Serum
259
725
3.81
80.02
2.1
1.2
u/ml
14.6
6.4
0.65
11
12
(3011397) Hemoglobin [Presence] in Urine by Test strip
900
4867
2.21
79.02
4.1
3.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
239
642
3.96
78.25
1.4
1.1
u/ml
2.2
0.7
0.56
22
54
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
202
487
4.37
76.46
2.0
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
141
260
5.64
73.16
1.4
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1014
5910
2.08
72.09
3.8
2.8
e6/l
0.3
0.4
1.78
769
4362
(40760892) CBC W Ordered Manual Differential panel - Blood
887
4967
2.11
69.77
6.1
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
371
1432
2.81
67.11
4.7
3.8
%
0.0
0.5
0.93
88
358
(3021440) Promyelocytes/100 leukocytes in Blood
386
1527
2.75
66.59
4.7
3.9
%
0.1
0.1
0.15
102
432
(3002582) Erythrocytes [#/volume] in Urine
1068
6488
2.00
66.56
4.0
2.9
e6/l
48.7
104.0
1.20
837
4880
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1214
7712
1.96
66.43
4.3
2.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2800
24091
3.27
66.29
22.5
11.4
mg/l
23.3
24.0
0.57
2502
18221
(3017181) Myelocytes/100 leukocytes in Blood
398
1604
2.71
66.20
4.7
3.9
%
0.7
0.9
0.20
102
465
(3017143) Hepatitis C virus Ab [Presence] in Serum
559
2678
2.33
64.13
1.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
382
1533
2.71
63.97
3.1
2.7
g/l
10.9
10.6
0.61
364
1392
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1347
8976
1.90
62.85
2.7
2.1
nmol/l
75.6
75.9
0.17
1274
8115
(3002179) Metamyelocytes/100 leukocytes in Blood
368
1466
2.72
62.45
4.3
3.8
%
0.5
0.7
0.77
80
337
(36304419) Bacteria [Presence] in Urine
968
5836
1.97
60.47
3.7
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
677
3584
2.15
60.46
3.0
2.5
e6/l
0.9
1.2
1.22
377
1952
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
204
587
3.65
60.24
1.6
1.5
titre
665.0
248.2
—
8
17
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
258
877
3.12
58.39
1.9
2.0
u/l
37.3
39.4
0.95
239
793
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
175
466
3.93
57.77
1.9
1.2
iu/ml
19.4
3.9
—
9
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
70
80
8.93
56.21
1.1
1.1
iu/ml
195.1
210.6
0.13
70
80
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
641
3416
2.11
55.76
3.2
2.6
e6/l
3.3
2.6
0.49
343
1795
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1499
10609
1.82
55.37
7.5
6.6
mmol/l
1.2
1.2
1.23
1328
8932
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
175
483
3.78
54.88
2.7
1.2
g/l
0.2
0.2
1.57
168
457
(3031040) Bacteria [#/volume] in Urine by Automated count
1928
14798
1.84
53.76
5.1
3.8
e6/l
1504.9
2463.2
0.32
15
195
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
179
510
3.67
53.57
2.6
1.2
g/l
1.2
1.2
0.15
171
483
(3021879) Hepatitis B virus core Ab [Presence] in Serum
384
1680
2.47
53.37
1.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
737
4209
1.99
52.66
3.3
2.5
mosm/kgh2o
562.4
553.3
0.51
640
3562
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
160
433
3.85
51.58
1.3
1.1
u/ml
6.7
3.9
0.44
27
48
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
158
427
3.85
51.03
1.3
1.1
u/ml
3.1
2.3
0.43
19
28
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
853
5175
1.90
50.67
2.5
2.1
mg/l
2.7
2.8
0.80
748
4354
(3004588) Protein electrophoresis panel - Serum or Plasma
281
1089
2.74
49.93
2.4
2.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
133
322
4.27
49.91
1.3
1.1
u/ml
1.2
1.6
0.56
11
18
(3000850) Epithelial cells [#/volume] in Urine
746
4383
1.93
48.51
3.1
2.4
e6/l
4.4
6.2
5.15
664
3812
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
166
481
3.59
48.41
1.3
1.1
u/ml
29.1
16.4
—
10
20
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
181
555
3.41
48.38
2.0
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1320
9308
1.74
46.67
5.6
4.9
g/l
35.5
35.9
2.35
1253
8658
(3028026) IgM [Mass/volume] in Serum or Plasma
296
1219
2.58
46.50
1.9
1.9
g/l
1.2
1.3
0.41
279
1116
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
203
685
3.11
46.34
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
515
2697
2.10
46.10
2.7
2.4
%
22.5
23.9
1.35
461
2320
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
808
4943
1.87
46.05
1.9
1.8
mg/l
1.1
1.1
0.17
636
3654
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
656
3755
1.95
45.75
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
777
4706
1.88
45.64
1.8
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
579
3178
2.02
45.54
2.6
2.4
umol/l
12.7
14.1
4.66
551
2946
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1562
11594
1.72
45.47
6.6
6.4
umol/l
11.0
11.4
0.48
1495
11011
(3002385) Erythrocyte distribution width [Ratio]
2431
20509
1.96
45.45
24.4
14.2
%
13.7
13.6
4.28
2407
19999
(3020630) Protein [Mass/volume] in Serum or Plasma
324
1418
2.44
44.66
2.7
3.1
g/l
67.1
66.4
0.97
297
1295
(3048689) Calprotectin [Mass/mass] in Stool
528
2823
2.06
44.57
2.7
2.3
ug/g
144.6
129.0
0.40
448
2248
(3007164) IgA [Mass/volume] in Serum or Plasma
757
4593
1.87
43.98
1.6
1.4
g/l
2.6
2.3
2.88
485
2863
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
955
6244
1.77
43.21
2.3
2.1
u/l
219.3
261.0
0.25
902
5880
(3004789) Transferrin [Mass/volume] in Serum or Plasma
538
2927
2.02
43.16
2.6
2.3
g/l
2.3
2.4
1.46
509
2709
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
72
117
6.28
42.49
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
72
117
6.28
42.49
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
72
118
6.23
42.14
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
72
118
6.23
42.14
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
72
118
6.23
42.14
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
72
119
6.17
41.79
1.2
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
942
6194
1.76
41.44
4.7
3.9
ph
7.4
7.4
0.10
140
1177
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1320
9556
1.68
40.55
7.4
5.9
mmol/l
1.2
1.2
0.38
1241
8620
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
51
60
8.63
40.01
2.5
3.0
mg/l
8.3
9.0
0.27
40
53
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
565
3223
1.93
39.17
2.1
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
123
338
3.75
38.76
3.8
3.3
e9/l
4.2
4.0
0.70
123
338
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
46
53
8.80
36.67
2.6
2.3
au/ml
194.8
62.5
—
5
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
123
351
3.61
36.67
4.0
3.6
%
57.8
56.9
0.34
123
351
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
553
3201
1.89
36.42
2.1
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1370
10204
1.63
36.31
3.2
2.7
ug/l
151.4
119.7
1.73
1308
9518
(3039162) Centromere protein B Ab [Units/volume] in Serum
86
191
4.61
36.00
1.3
1.1
u/ml
25.0
6.5
—
7
5
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
125
366
3.52
35.85
1.3
1.1
u/ml
51.6
25.3
0.98
13
28
(3007853) Bacteria identified in Skin by Aerobe culture
459
2510
1.98
35.77
2.0
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
506
2868
1.92
35.45
1.9
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
305
1438
2.25
35.13
1.7
1.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
172
622
2.87
34.64
2.3
2.7
g/l
7.4
7.1
1.93
131
467
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
171
622
2.85
34.06
2.3
2.7
g/l
4.0
3.7
1.46
129
444
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
171
622
2.85
34.06
2.3
2.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
414
2223
2.00
33.88
1.9
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
575
2.92
33.75
2.3
2.7
g/l
10.5
10.4
0.02
140
484
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
119
351
3.49
33.75
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
154
534
2.99
33.45
2.5
2.7
g/l
0.4
1.3
3.56
130
459
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2850
26174
2.61
33.38
16.7
8.6
u/l
26.5
27.0
0.91
2814
25227
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
410
2210
1.99
33.14
1.9
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
145
491
3.05
32.83
2.4
2.5
g/l
37.8
38.2
0.32
125
422
(3033658) Prothrombin time (PT) actual/Normal
852
5757
1.67
32.38
4.7
3.9
%
92.4
91.7
0.35
832
5611
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1083
7807
1.60
31.56
3.6
3.2
u/l
35.0
34.5
0.07
1033
7429
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
160
588
2.82
31.26
2.3
2.7
g/l
3.2
3.0
1.44
129
454
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
151
539
2.90
31.13
1.9
2.1
mg/l
10.9
10.7
0.11
145
498
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1169
8601
1.59
31.12
2.1
1.8
pmol/l
94.0
95.8
0.72
693
4492
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2570
22831
1.85
31.08
17.6
10.7
ml/min/173m2
86.6
84.7
4.77
2301
18501
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
48
71
6.85
30.99
1.2
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
138
470
3.03
30.93
2.5
2.6
g/l
0.0
0.0
0.28
129
424
(3013826) Glucose [Moles/volume] in Serum or Plasma
1648
13131
1.56
30.79
5.7
4.6
mmol/l
6.6
6.7
0.40
1548
12188
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1162
8560
1.58
30.64
4.8
3.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
29
22
13.30
30.55
1.5
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
272
1304
2.19
29.94
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
886
6146
1.63
29.91
4.1
2.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
129
438
3.03
29.08
2.5
2.6
g/l
0.0
0.0
0.00
120
401
(3032080) INR in Blood by Coagulation assay
1126
8309
1.57
29.06
10.2
8.1
inr
1.2
1.2
0.18
302
2482
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
129
445
2.98
28.28
2.6
2.6
g/l
0.0
0.0
0.00
120
401
(3052851) Hemolysis interference index of Serum or Plasma
157
604
2.69
28.09
2.5
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2711
24698
1.97
27.54
20.0
13.4
mmol/l
139.5
139.7
5.68
2674
23987
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
395
2237
1.88
27.27
3.4
4.6
u/l
234.1
240.9
0.34
374
2118
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
38
50
7.68
27.19
1.8
2.8
mg/l
8.3
10.1
0.73
31
41
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
129
457
2.90
26.97
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2574
23168
1.76
25.93
22.4
12.5
%
39.2
40.3
7.48
1986
17707
(3023103) Potassium [Moles/volume] in Serum or Plasma
2710
24802
1.91
25.42
20.1
13.5
mmol/l
3.9
4.0
2.37
2670
24034
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1307
10168
1.50
25.40
4.3
3.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
766
5333
1.58
24.63
1.3
1.3
u/ml
1.8
1.8
0.03
183
1403
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
629
4180
1.64
24.51
3.7
3.3
ng/l
282.4
751.1
1.07
453
2998
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
436
2626
1.77
24.46
3.1
2.9
umol/l
8.4
8.2
0.04
373
2290
(42529406) Shigella sp [Presence] in Stool by Culture
154
634
2.51
24.00
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
153
628
2.51
24.00
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
281
1487
1.98
23.63
2.4
2.7
e9/l
4.1
4.1
0.09
223
1213
(3044640) Blood type and Crossmatch panel - Blood
932
6853
1.52
23.19
2.8
2.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
370
2163
1.81
22.87
2.7
2.7
%
1.7
1.7
0.65
334
1925
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
944
7002
1.51
22.36
3.0
2.6
u/l
58.9
58.1
0.11
887
6482
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
149
626
2.45
22.24
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
212
1036
2.13
22.13
4.0
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
746
5281
1.55
21.89
3.3
2.9
ng/l
1607.8
1235.5
0.88
655
4430
(3002032) Base excess in Venous blood by calculation
338
1949
1.83
21.81
4.5
3.8
mmol/l
1.7
1.9
0.21
275
1571
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1969
16899
1.48
21.80
3.5
3.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
180
836
2.23
21.34
1.9
1.8
g/l
1.7
1.5
2.21
149
716
(40761511) CBC panel - Blood by Automated count
2767
25741
1.91
21.11
17.0
10.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
336
1953
1.81
21.10
4.6
3.8
kpa
5.7
5.8
1.71
331
1896
(3021960) Folate [Moles/volume] in Serum or Plasma
662
4619
1.56
20.55
1.7
1.5
nmol/l
22.4
20.3
1.26
585
3977
(3037756) Immunofixation for Serum or Plasma
93
321
2.96
20.42
1.5
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
833
6116
1.50
20.36
3.2
2.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
97
345
2.87
20.18
1.4
1.7
g/l
0.5
0.8
2.08
69
258
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
124
501
2.54
20.13
3.4
4.1
mg/l
31.6
54.4
1.12
101
415
(3034860) Kappa light chains.free [Mass/volume] in Serum
123
500
2.52
19.72
3.5
4.2
mg/l
55.3
50.4
0.16
99
412
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2451
22196
1.56
19.33
4.8
4.5
mu/l
3.3
2.2
0.56
2317
20465
(3015377) Calcium [Moles/volume] in Serum or Plasma
968
7400
1.45
19.01
3.3
3.5
mmol/l
2.3
2.4
1.00
869
6566
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
676
4812
1.52
18.95
1.7
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
66
195
3.44
18.76
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
79
265
3.03
18.27
2.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
410
2619
1.65
18.23
1.7
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
111
448
2.53
18.08
5.6
6.4
iu/ml
490.7
842.1
0.46
11
72
(3047007) Chlamydophila sp Ab [Presence] in Serum
96
361
2.71
18.02
1.4
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
214
1131
1.96
17.99
1.7
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2908
27728
2.36
17.83
30.4
17.0
e9/l
262.6
252.7
12.73
2883
26958
(3024354) Oxygen [Partial pressure] in Venous blood
277
1596
1.81
17.82
3.8
3.3
kpa
4.3
4.6
2.31
271
1546
(3003338) MCHC [Mass/volume]
2393
21688
1.50
17.50
26.3
14.7
g/l
331.9
333.2
10.81
2384
21504
(3024731) MCV [Entitic volume]
2908
27749
2.34
17.43
30.3
16.9
fl
91.1
90.6
9.54
2900
27312
(3036481) Cortisol [Moles/volume] in Serum or Plasma
336
2063
1.71
17.32
2.2
2.2
nmol/l
345.3
381.6
2.89
314
1886
(3026361) Erythrocytes [#/volume] in Blood
2908
27756
2.33
17.30
30.4
16.9
e12/l
4.5
4.6
18.50
2874
26928
(3035941) MCH [Entitic mass]
2907
27751
2.32
17.14
30.3
16.9
pg
30.3
30.3
0.82
2900
27312
(3010813) Leukocytes [#/volume] in Blood
2908
27765
2.32
17.13
30.5
17.0
e9/l
6.9
6.6
8.90
2877
26934
(3000963) Hemoglobin [Mass/volume] in Blood
2908
27766
2.32
17.11
30.6
17.0
g/l
134.3
136.9
19.34
2897
27325
(3012095) Magnesium [Moles/volume] in Serum or Plasma
517
3546
1.55
16.99
4.0
3.7
mmol/l
0.8
0.8
1.50
491
3330
(3044889) 12 lead EKG panel
1882
16367
1.40
16.88
3.8
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
705
5175
1.47
16.72
2.7
2.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
154
744
2.13
16.56
2.2
2.0
ug/l
1.0
1.4
0.73
143
670
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
134
614
2.24
16.45
3.0
2.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
120
526
2.33
16.35
4.6
4.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
518
3585
1.54
16.29
1.8
1.7
nmol/l
1076.7
1128.3
0.67
420
2738
(3014576) Chloride [Moles/volume] in Serum or Plasma
404
2643
1.61
16.22
9.5
7.3
mmol/l
104.8
104.5
0.65
396
2585
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
551
3868
1.52
16.21
2.9
3.1
mmol/l
2.4
2.4
0.04
487
3380
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
345
2173
1.66
16.11
2.7
2.5
u/l
36.8
63.5
0.64
298
1884
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
250
1441
1.80
16.04
3.8
3.9
ng/l
94.2
86.6
0.54
228
1251
(3023520) Reticulocytes [#/volume] in Blood
263
1539
1.78
16.04
2.7
2.7
e9/l
66.0
69.7
0.95
185
1144
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1021
8072
1.40
15.98
4.0
3.2
ng/l
46.3
54.3
0.23
626
5008
(3003458) Phosphate [Moles/volume] in Serum or Plasma
409
2702
1.59
15.74
6.8
6.2
mmol/l
1.0
1.0
0.45
384
2520
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
43
109
3.99
15.30
1.2
1.1
u/ml
2.2
2.5
—
5
6
(3020779) Urea [Moles/volume] in Serum or Plasma
301
1858
1.69
15.15
8.3
7.8
mmol/l
9.5
8.9
0.82
285
1771
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2080
18560
1.39
14.91
4.0
3.9
pmol/l
14.6
14.6
0.17
1951
17002
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
54
164
3.33
14.77
1.3
1.2
titre
314.4
232.1
0.25
16
28
(3004716) Salmonella sp identified in Stool by Organism specific culture
218
1240
1.82
14.61
1.4
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
62
209
3.01
14.28
1.4
1.3
g/l
0.4
0.4
0.20
48
144
(3028192) IgG subclass 2 [Mass/volume] in Serum
62
209
3.01
14.28
1.4
1.3
g/l
3.3
3.0
0.60
47
144
(3019150) Specific gravity of Urine by Refractometry
640
4737
1.45
14.24
5.0
3.2
kg/l
1.0
1.0
0.55
109
672
(3007566) Smooth muscle Ab [Titer] in Serum
129
621
2.13
14.04
1.2
1.3
titre
95.0
84.1
0.15
14
54
(3014111) Lactate [Moles/volume] in Serum or Plasma
293
1834
1.66
13.97
7.8
7.6
mmol/l
1.3
1.4
0.54
285
1765
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
133
650
2.09
13.91
2.2
2.4
ug/l
158.5
518.4
3.64
123
615
(3038515) Glucose [Moles/volume] in Venous blood
98
423
2.36
13.87
4.3
3.0
mmol/l
7.1
7.5
0.83
98
413
(3027135) IgG subclass 1 [Mass/volume] in Serum
61
209
2.96
13.67
1.4
1.3
g/l
6.5
6.6
0.12
47
142
(4062490)
61
211
2.93
13.45
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
100
443
2.30
13.35
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
100
443
2.30
13.35
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
256
1565
1.69
13.34
2.6
2.7
ng/l
160.5
173.7
0.23
230
1417
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
95
412
2.35
13.32
1.6
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
147
758
1.99
13.29
1.9
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
279
1756
1.65
13.00
9.4
8.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
100
450
2.26
12.88
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
430
2999
1.51
12.83
1.3
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
100
452
2.25
12.75
4.3
2.9
mmol/l
1.4
1.5
0.80
100
438
(40761535) Cells panel - Urine sediment
258
1603
1.67
12.64
4.3
2.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
60
4.70
12.35
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
267
2.62
12.35
1.6
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
743
5770
1.38
12.32
5.3
3.3
estimate
0.0
0.0
1.34
296
1887
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
128
646
2.02
12.31
1.3
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
106
498
2.17
12.31
1.8
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
80
335
2.43
12.15
1.6
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
469
3364
1.47
12.13
2.2
2.2
s
30.3
29.7
1.00
455
3275
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
131
672
1.99
12.05
1.7
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
83
355
2.38
12.03
1.8
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
81
345
2.39
11.86
1.2
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
37
102
3.66
11.76
1.9
3.0
u/ml
618.4
1246.3
1.43
37
102
(3005322) IgE [Units/volume] in Serum or Plasma
242
1509
1.66
11.69
1.4
1.3
u/ml
226.6
226.2
0.00
227
1395
(3024891) Influenza virus A+B Ag [Presence] in Specimen
126
645
2.00
11.66
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
289
1889
1.59
11.53
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
52
180
2.92
11.50
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
75
313
2.43
11.49
2.2
3.6
%
0.9
1.4
0.44
60
249
(3044927) Protein electrophoresis panel - Urine
47
154
3.08
11.43
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
43
134
3.24
11.36
1.8
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
55
200
2.78
11.13
1.3
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
224
1389
1.66
11.06
3.3
2.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
33
88
3.78
11.01
1.4
1.3
u/l
5.8
8.0
0.58
24
73
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
101
487
2.11
11.01
1.8
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2352
21775
1.36
10.92
5.8
5.1
mmol/mol
39.2
39.3
0.18
2242
20191
(3034770) Mitochondria Ab [Titer] in Serum
120
621
1.97
10.79
1.2
1.3
—
1341.3
—
0
16
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
62
244
2.57
10.77
1.5
1.5
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
13
14
9.32
10.76
3.2
1.0
titre
182.0
—
—
5
0
(3022145) Colonoscopy Study observation
362
2523
1.49
10.76
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
69
286
2.45
10.75
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
27
64
4.25
10.55
1.7
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
83
377
2.24
10.52
3.2
4.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
98
478
2.09
10.38
1.3
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
303
2054
1.53
10.27
2.6
2.2
g/l
0.2
0.2
0.11
279
1927
(3041354) Potassium [Moles/volume] in Venous blood
64
263
2.46
10.18
2.4
2.4
mmol/l
4.0
4.0
0.16
64
257
(3035285) Chloride [Moles/volume] in Venous blood
64
263
2.46
10.18
2.4
2.4
mmol/l
106.0
105.2
0.81
64
257
(3013512) EKG study
762
6099
1.33
10.08
4.4
3.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
66
277
2.41
10.04
1.6
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
63
260
2.45
9.94
2.4
2.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
176
1058
1.70
9.78
3.3
2.5
e6/l
0.4
0.2
0.46
170
1026
(40768804) Tissue Pathology biopsy report
1135
9622
1.29
9.78
2.1
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
144
818
1.80
9.75
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
157
915
1.76
9.74
2.1
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
54
209
2.61
9.73
2.1
2.9
e9/l
1.2
1.2
0.09
36
118
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
36
112
3.24
9.58
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
796
6455
1.32
9.52
4.1
3.9
mg/mmol
15.8
8.6
2.32
535
4080
(3022217) INR in Platelet poor plasma by Coagulation assay
354
2516
1.46
9.50
28.8
20.9
inr
1.4
1.3
0.40
55
349
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
48
178
2.72
9.41
1.3
1.1
u/l
49.1
62.9
1.24
39
122
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
58
237
2.48
9.36
1.8
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
168
1010
1.70
9.34
4.0
4.1
mmol/l
23.8
24.0
0.43
158
926
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
41
142
2.91
9.12
2.2
2.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
32
96
3.36
9.03
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
50
194
2.60
8.99
4.5
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
153
907
1.72
8.96
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
104
548
1.93
8.93
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
171
1051
1.66
8.77
2.4
2.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
141
823
1.75
8.73
5.3
6.2
%
0.9
0.9
0.39
133
764
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1850
16782
1.26
8.68
3.7
3.0
u/l
52.1
45.8
2.53
1756
15805
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
142
833
1.74
8.64
5.4
6.2
%
1.7
1.6
0.40
134
771
(3026480) Teichoate Ab [Titer] in Serum
10
10
10.03
8.64
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
54
223
2.45
8.55
1.7
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
380
2793
1.41
8.47
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
59
255
2.34
8.46
1.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
82
406
2.05
8.42
1.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
162
996
1.66
8.31
3.5
2.7
%
1.2
1.3
1.00
162
988
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
58
251
2.34
8.30
1.4
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
91
471
1.96
8.26
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
129
747
1.76
8.23
2.1
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
58
253
2.32
8.16
1.4
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
11
9.12
8.09
1.1
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
12
7
17.21
8.07
1.3
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
265
1837
1.49
8.06
2.2
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
139
831
1.71
7.93
2.2
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
191
1241
1.58
7.84
3.7
3.5
kpa
5.1
5.2
1.00
175
1162
(3000093) Morphology [Interpretation] in Blood Narrative
44
172
2.58
7.84
1.1
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
189
1227
1.58
7.79
3.6
3.5
ph
7.4
7.4
0.07
23
149
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
161
2.63
7.78
2.2
2.4
%
13.7
13.0
0.13
27
63
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
112
2.97
7.65
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
744
6129
1.28
7.65
3.4
3.2
mg/l
344.2
316.5
0.07
487
3842
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2472
23382
1.32
7.61
4.5
4.1
mmol/l
5.9
5.9
0.80
2314
21471
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
84
436
1.95
7.59
1.3
1.5
u/ml
114.8
108.7
0.29
17
83
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
12
8.36
7.58
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
187
1221
1.57
7.52
1.5
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
82
3.31
7.51
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
94
509
1.87
7.49
1.2
1.5
e6/l
223.1
1274.4
1.25
85
414
(3025468) Yersinia sp identified in Specimen by Organism specific culture
55
244
2.28
7.47
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
114
656
1.77
7.46
4.4
3.6
u/ml
0.3
0.3
0.10
71
360
(3005988) Vibrio sp identified in Specimen by Organism specific culture
55
245
2.27
7.40
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
55
245
2.27
7.40
1.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
57
258
2.23
7.39
3.4
2.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
108
616
1.78
7.29
1.4
1.4
ug/g
264.9
279.8
0.28
54
354
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
70
346
2.05
7.27
1.2
1.2
u/ml
1.7
2.8
0.90
28
109
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
93
508
1.86
7.23
1.2
1.5
e6/l
105.6
12.7
0.89
78
393
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
195
1298
1.54
7.21
7.6
7.9
mmol/l
24.8
24.8
0.03
190
1290
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
52
229
2.29
7.20
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
811
6795
1.26
7.20
3.2
3.2
mmol/l
7.5
7.9
1.40
691
5781
(3017354) Segmented neutrophils/100 leukocytes in Blood
45
186
2.44
7.17
2.5
3.7
%
58.3
57.3
0.09
27
123
(3032773) Endomysium IgG Ab [Titer] in Serum
47
200
2.37
7.04
1.2
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
284
2048
1.43
7.04
10.0
8.8
%
95.9
95.8
0.05
271
1970
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
61
3.63
7.02
1.7
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
52
232
2.26
6.99
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
79
414
1.93
6.98
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
55
252
2.20
6.94
8.3
6.8
mg/l
11.5
12.0
0.29
50
235
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
180
1188
1.55
6.93
3.6
3.4
mmol/l
1.4
1.7
0.53
135
868
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
48
209
2.32
6.84
1.0
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
45
191
2.38
6.79
1.8
2.6
%
48.8
44.0
—
5
29
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
162
1050
1.57
6.76
10.9
10.8
mmol/l
24.4
24.2
0.43
153
999
(3009871) Measles virus Ab [Titer] in Serum
24
73
3.31
6.68
2.0
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
88
485
1.84
6.68
1.2
1.3
u/ml
277.1
255.1
0.28
51
299
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
39
157
2.50
6.59
1.1
1.1
iu/ml
7.3
10.5
—
5
48
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
49
219
2.26
6.58
2.0
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
313
2323
1.39
6.57
9.4
8.1
mmol/l
1.0
1.0
0.04
244
1790
(3000492) Spirometry study
320
2385
1.38
6.55
1.7
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
121
737
1.67
6.50
2.7
2.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
114
684
1.69
6.48
2.8
2.7
%
186.4
185.8
0.02
109
652
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
312
2324
1.38
6.41
9.5
8.2
kpa
5.1
5.1
0.03
294
2213
(3036489) Thrombin time
137
868
1.61
6.31
2.4
2.3
s
21.9
21.4
0.23
121
760
(3037121) Protein [Mass/volume] in Urine
117
713
1.67
6.28
3.0
3.4
g/l
0.4
0.3
0.49
60
302
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
91
517
1.78
6.28
1.2
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
311
2324
1.38
6.27
9.5
8.1
kpa
12.1
12.8
1.77
294
2218
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
6
0
+∞
6.25
1.0
0.0
mg/l
23.7
—
—
6
0
(21494890) Protein electrophoresis panel - 24 hour Urine
41
175
2.36
6.14
2.3
2.6
—
—
—
0
0
(44806118)
51
239
2.15
6.13
1.7
1.5
—
—
—
0
0
(44790049)
51
239
2.15
6.13
1.7
1.5
—
—
—
0
0
(44790047)
51
239
2.15
6.13
1.7
1.5
—
—
—
0
0
(44790048)
51
239
2.15
6.13
1.7
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
82
456
1.82
6.08
2.5
1.9
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
14
31
4.53
5.98
1.4
1.4
ug/l
0.3
0.4
—
5
17
(3008757) Leukocyte morphology finding [Identifier] in Blood
45
203
2.24
5.95
3.2
4.6
—
—
—
0
0
(4010399)
218
1549
1.44
5.88
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
1111
1.51
5.84
10.7
11.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
554
4535
1.27
5.83
1.8
1.6
pmol/l
44280075.6
36523305.2
0.11
472
3825
(3028626) Oxygen [Partial pressure] in Capillary blood
82
463
1.79
5.80
2.7
3.2
kpa
8.2
8.4
0.47
75
435
(3002173) Hemoglobin [Mass/volume] in Arterial blood
260
1911
1.39
5.80
10.7
9.1
g/l
119.3
123.5
2.55
252
1838
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
32
125
2.58
5.79
1.6
1.5
u/ml
13.7
20.3
—
6
26
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
114
2.65
5.73
2.5
3.3
%
37.7
40.9
0.32
14
36
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
206
1456
1.45
5.72
2.1
1.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
120
755
1.61
5.72
2.3
2.5
%
95.0
91.9
0.72
114
707
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
57
288
2.00
5.65
1.3
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
121
2.58
5.62
1.5
1.6
—
—
—
0
0
(3036603) Volume of Urine
35
145
2.43
5.62
1.7
1.5
ml
1857.8
2058.7
0.40
12
28
(3000060) B lymphocytes [#/volume] in Blood
19
56
3.41
5.58
2.6
2.7
e6/l
97.7
182.2
1.24
13
32
(3025018) Bordetella pertussis Ab [Titer] in Serum
35
147
2.40
5.46
1.5
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
15
38
3.96
5.44
1.2
1.1
%
101.7
98.4
0.19
15
38
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
38
3.96
5.44
1.2
1.1
—
—
—
0
0
(4268621)
48
231
2.10
5.44
2.1
2.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
83
483
1.74
5.33
2.9
3.2
mmol/l
24.5
24.9
0.27
69
430
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
10
18
5.57
5.32
5.0
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
62
330
1.90
5.31
1.2
1.2
u/ml
2.1
4.3
2.10
27
146
(3029075) Extractable nuclear Ab panel - Serum
19
58
3.29
5.30
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
39
175
2.24
5.26
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
176
2.23
5.19
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
65
355
1.85
5.16
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
65
356
1.84
5.12
2.6
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
37
165
2.26
5.07
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
48
238
2.03
5.05
1.3
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
45
218
2.08
5.03
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
27
4.46
5.03
2.3
2.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
55
3.29
5.02
2.6
1.9
iu/ml
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
56
294
1.92
5.02
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
37
166
2.24
5.00
2.1
3.1
e6/l
814.3
710.7
0.38
15
76
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
37
166
2.24
5.00
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2560
24615
1.26
5.00
4.9
4.4
mmol/l
2.8
2.8
1.43
2414
22873
(3019832) Treponema pallidum Ab [Presence] in Serum
331
2589
1.31
4.93
1.7
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
227
1678
1.38
4.92
2.9
2.4
ml/min/173m2
71.3
71.4
0.02
99
631
(3051611) Lipemic interference index of Serum or Plasma
42
200
2.12
4.92
2.9
3.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
29
118
2.47
4.87
1.9
1.5
u/l
6.8
5.7
0.13
19
56
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
230
1710
1.37
4.82
4.2
3.8
mmol/l
1.2
1.2
0.20
207
1473
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
34
150
2.28
4.79
1.5
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
69
2.91
4.60
2.4
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
212
1568
1.38
4.59
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
74
437
1.71
4.56
2.3
2.2
g/l
131.1
131.6
0.06
50
313
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
399
3255
1.26
4.28
1.8
1.8
%
1.5
1.4
0.31
346
2917
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
9
8.91
4.28
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
708
6133
1.20
4.27
1.6
1.6
mmol/l
1.5
1.4
1.75
617
5176
(40761536) Microorganisms panel - Urine sediment
248
1902
1.33
4.27
4.7
3.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
56
3.05
4.24
1.4
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
102
2.46
4.21
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
70
417
1.69
4.21
1.6
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
131
904
1.47
4.20
3.7
3.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
65
380
1.73
4.18
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
58
328
1.78
4.18
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
116
782
1.50
4.17
4.0
3.6
mmol/l
24.7
24.8
0.11
107
732
(3009677) Dengue virus Ab [Presence] in Serum
9
13
6.94
4.16
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
37
181
2.06
4.09
1.5
1.2
u/ml
0.1
0.7
0.91
23
80
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
168
2.10
4.07
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
15
47
3.20
4.05
1.7
2.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
22
86
2.57
4.05
1.7
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
7
10.02
4.01
3.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
25
105
2.39
3.98
1.4
1.4
—
55.3
—
0
15
(4306422)
61
356
1.73
3.97
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2499
24100
1.22
3.93
4.4
4.0
mmol/l
1.4
1.5
1.19
2362
22419
(3045424) Erythrocytes [Presence] in Urine
59
343
1.73
3.90
1.7
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
72
443
1.64
3.86
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2512
24249
1.21
3.85
4.4
4.0
mmol/l
4.7
4.7
1.09
2383
22670
(3003740) Influenza virus B Ag [Presence] in Specimen
72
444
1.64
3.83
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
594
1.55
3.82
3.4
4.1
mg/l
1.5
1.4
0.94
82
553
(3024928) Oxygen saturation in Venous blood
73
453
1.63
3.79
3.1
3.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
28
127
2.22
3.76
1.1
1.1
nmol/l
0.2
2.0
—
5
25
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
127
2.22
3.76
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
44
237
1.87
3.74
1.2
1.7
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
15
50
3.01
3.68
1.4
1.3
nmol/l
275.8
146.4
—
10
38
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
67
2.70
3.65
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
67
2.70
3.65
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
72
450
1.61
3.65
4.7
3.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
34
169
2.02
3.64
1.6
2.1
u/field
1.8
2.3
0.25
13
74
(3047189) Immunofixation for 24 hour Urine
22
91
2.43
3.63
2.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
155
1137
1.38
3.59
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
33
164
2.02
3.54
2.9
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
262
2080
1.28
3.54
4.3
3.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
8
13
6.17
3.50
1.9
1.7
mg/l
2.5
3.6
—
8
13
(3036048) Francisella tularensis Ab [Titer] in Serum
15
52
2.89
3.46
1.1
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
36
187
1.94
3.43
2.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
36
187
1.94
3.43
2.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
36
187
1.94
3.43
2.0
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
30
146
2.07
3.41
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
170
1278
1.35
3.40
13.3
10.0
%
0.7
0.7
0.33
165
1267
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
64
2.67
3.39
1.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
47
268
1.77
3.36
1.1
1.1
%
97.0
96.3
0.06
42
256
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
119
845
1.43
3.35
1.2
1.3
miu/ml
174.0
229.2
1.26
47
412
(3041672) Baker's yeast Ab [Presence] in Serum
8
14
5.73
3.34
1.1
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
32
3.45
3.33
1.5
3.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2408
23235
1.18
3.30
4.0
3.7
mmol/l
1.3
1.3
2.54
2261
21507
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
17
65
2.62
3.30
1.7
2.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
71
2.54
3.29
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
71
2.54
3.29
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
44
248
1.79
3.28
3.2
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
366
3056
1.22
3.20
1.3
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
10
28
3.58
3.19
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
33
3.34
3.19
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
33
3.34
3.19
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
33
3.34
3.19
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
33
3.34
3.19
1.1
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
104
2.22
3.15
1.5
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
58
358
1.63
3.14
1.1
1.1
%
117.8
115.1
0.28
52
326
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
105
2.20
3.09
1.5
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
19
80
2.38
3.06
1.8
1.2
g/l
0.3
0.3
0.05
13
68
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
172
1322
1.32
2.99
1.1
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
21
4.30
2.99
8.1
7.5
mmol/l
4.6
7.0
—
9
21
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
274
2239
1.25
2.94
3.5
4.4
ug/l
14.3
29.5
0.87
204
1813
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
213
1691
1.28
2.92
2.5
2.3
ug/l
5.7
8.0
1.83
178
1509
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
61
390
1.58
2.89
2.6
3.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
7
13
5.39
2.87
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
41
2.93
2.85
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
30
158
1.91
2.80
1.9
2.5
ml
678.5
591.8
0.42
17
110
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
90
2.23
2.80
1.3
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
90
2.23
2.80
1.3
1.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
71
475
1.51
2.76
5.8
4.1
kpa
8.4
8.7
0.82
66
467
(3032057) Clostridioides difficile [Presence] in Stool
12
42
2.86
2.75
2.0
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
46
279
1.66
2.70
2.2
2.5
—
—
—
0
0
(4027681)
27
139
1.95
2.70
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
169
1317
1.30
2.69
6.8
5.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
79
2.29
2.67
2.1
2.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
168
1.85
2.67
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
791
7151
1.14
2.66
4.5
4.5
ug/l
2.3
2.6
0.32
719
6441
(3023183) Ammonium ion [Moles/volume] in Plasma
70
475
1.48
2.57
4.0
3.2
umol/l
32.6
35.4
0.58
61
403
(3013290) Carbon dioxide [Partial pressure] in Blood
70
475
1.48
2.57
5.8
4.0
kpa
5.0
5.0
0.14
65
468
(3012501) Base excess in Blood by calculation
70
475
1.48
2.57
5.8
4.0
mmol/l
2.8
2.5
0.37
45
313
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
11
5.46
2.54
1.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
81
2.23
2.53
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
35
201
1.75
2.52
1.1
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
26
136
1.92
2.50
3.0
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
123
928
1.34
2.48
1.7
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
26
3.47
2.48
2.0
1.8
ng/l
203.4
121.2
—
9
26
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
27
144
1.88
2.46
1.3
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
76
2.24
2.44
5.0
4.3
—
—
—
0
0
(44813793)
28
152
1.85
2.42
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
27
3.34
2.39
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
52
337
1.55
2.38
1.5
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
77
2.21
2.37
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
94
686
1.38
2.36
1.1
1.1
u/ml
2.4
5.2
0.93
12
96
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
65
2.31
2.31
1.3
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
134
1.87
2.26
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
72
507
1.43
2.23
2.2
2.5
ug/min
72.9
124.4
0.83
34
326
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
58
392
1.49
2.21
1.0
1.1
u/ml
1.7
2.5
0.54
24
203
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
107
1.97
2.20
1.4
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
29
165
1.76
2.19
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
18
87
2.08
2.17
1.2
1.4
—
—
—
0
0
(3010421) pH of Blood
79
569
1.40
2.16
5.6
4.0
ph
7.4
7.4
0.32
66
468
(21494434) Karyotype in Bone marrow
31
181
1.72
2.15
1.1
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
25
137
1.83
2.13
1.3
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
35
212
1.66
2.13
1.5
1.4
promille
2.0
1.3
1.76
26
166
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
267
1.58
2.11
1.1
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
88
2.05
2.11
3.8
2.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
158
1265
1.26
2.10
10.5
7.5
mmol/l
24.5
24.4
0.12
144
1180
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
17
82
2.08
2.06
1.8
2.2
%
155.6
150.0
0.13
17
77
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
69
2.18
2.04
1.1
1.3
%
99.9
86.2
—
8
36
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
15
4.01
2.04
1.2
1.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
8
26
3.08
2.01
1.0
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
61
426
1.44
2.00
3.5
2.4
%
16.1
16.8
0.60
34
205
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
97
1.96
2.00
2.1
3.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
48
320
1.51
1.98
1.3
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
15
70
2.15
1.98
1.5
2.6
u/ml
900.6
36366.5
—
5
13
(3033799) Differential panel - Peritoneal fluid
15
70
2.15
1.98
1.4
2.0
—
—
—
0
0
(3019225) pH of Specimen
242
2046
1.20
1.94
5.2
4.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
45
2.45
1.93
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
39
2.57
1.92
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
78
2.06
1.90
1.1
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
20
106
1.89
1.90
2.9
2.6
u/l
195.3
204.2
0.27
20
106
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
22
3.19
1.88
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
136
1.77
1.87
1.1
1.1
ratio
1.1
1.1
—
6
55
(3016750) Collection duration of Urine
21
114
1.85
1.87
1.7
2.4
min
497.8
493.1
0.08
12
87
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
40
2.50
1.83
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
746
6865
1.12
1.83
1.5
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
94
1.92
1.80
1.4
3.2
umol/l
75.8
178.7
—
6
54
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
8
29
2.76
1.79
1.0
1.1
u/ml
0.0
0.0
—
8
19
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
29
2.76
1.79
2.9
2.4
—
—
—
0
0
(3017704) Immunofixation for Urine
19
102
1.87
1.76
2.2
1.9
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
10
41
2.44
1.75
1.0
1.1
mg/g
11.1
7.1
—
10
41
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
18
3.34
1.74
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
66
483
1.37
1.71
3.6
3.3
mg/l
27.0
26.1
0.08
50
293
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
52
365
1.43
1.70
1.4
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
118
1.79
1.70
2.5
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
118
1.79
1.70
2.5
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
118
1.79
1.70
2.5
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
118
1.79
1.70
2.5
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
111
1.81
1.68
1.1
1.1
miu/ml
1981.6
1531.8
0.72
20
111
(3047181) Lactate [Moles/volume] in Blood
86
658
1.32
1.67
5.7
7.3
mmol/l
1.3
1.3
0.10
78
566
(3039000) Anion gap in Blood
64
468
1.38
1.67
6.4
8.7
mmol/l
11.5
11.4
0.07
57
413
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
19
3.16
1.66
1.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
31
2.58
1.66
7.4
6.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
64
469
1.37
1.65
6.4
8.7
mmol/l
103.6
105.5
1.97
57
414
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
103
810
1.28
1.64
3.5
3.8
u/ml
150.1
5914.0
1.01
81
699
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
76
1.98
1.64
1.0
1.2
—
—
—
0
0
(3025315) Body weight
5
14
3.58
1.61
4.4
2.6
—
—
—
0
0
(4211845)
18
98
1.84
1.61
3.8
2.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
18
98
1.84
1.61
1.1
1.1
u/l
111.7
20.7
0.56
13
68
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
92
715
1.30
1.61
1.7
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
50
2.20
1.57
1.9
1.4
ug/l
8.8
9.0
0.07
11
50
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
465
4205
1.13
1.55
2.8
2.8
ug/l
0.7
0.8
0.22
304
2586
(3011648) Oxygen content in Venous blood
27
168
1.61
1.55
2.0
3.0
%
10.0
11.4
1.03
27
168
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
57
2.11
1.55
1.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
78
1.93
1.54
2.0
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
154
1844
0.83
1.53
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
126
1026
1.24
1.52
1.9
2.3
u/l
3485.7
4589.0
0.22
41
405
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
27
2.60
1.51
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
2.2
1.9
umol/l
54.3
37.6
—
6
21
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
131
1.68
1.49
1.0
1.1
u/l
0.9
1.1
—
7
67
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
72
1.95
1.48
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
14
72
1.95
1.48
1.1
1.1
%
93.3
87.1
—
7
38
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
20
116
1.73
1.48
1.6
1.8
u/field
0.3
4.5
1.84
13
90
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
31
203
1.53
1.45
1.6
1.5
g/l
0.9
1.0
0.28
31
203
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
16
3.13
1.44
1.2
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
66
1.97
1.43
1.2
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
18
103
1.75
1.40
7.1
9.2
u/ml
63.4
53.3
—
5
35
(3023511) Choriogonadotropin [Units/volume] in Urine
70
536
1.31
1.40
1.4
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
27
177
1.53
1.28
1.6
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
48
2.09
1.27
1.1
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.29
1.26
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
220
1923
1.16
1.26
2.2
2.2
nmol/l
12.6
13.2
0.67
203
1715
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
16
92
1.74
1.25
2.2
2.3
ug/l
26.8
19.6
0.59
16
80
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
175
1505
1.17
1.24
3.4
3.5
pmol/l
4.5
4.5
0.42
153
1353
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
49
2.04
1.22
2.9
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
45
332
1.36
1.18
1.7
1.4
ug/l
5.3
4.1
0.20
38
299
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
38
2.11
1.18
2.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
16
94
1.71
1.17
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
242
2725
0.88
1.16
1.7
1.7
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
33
0.00
1.16
0.0
5.8
—
74.8
—
0
28
(4094501)
82
661
1.25
1.14
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
118
1.61
1.14
1.2
1.4
—
—
—
0
0
(4024509)
26
175
1.49
1.12
1.4
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
40
2.00
1.12
1.8
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
38
277
1.38
1.09
1.4
1.4
mu/l
63.1
57.3
0.11
28
248
(3026692) Albumin [Mass/volume] in Peritoneal fluid
12
66
1.82
1.09
1.1
1.5
g/l
14.6
12.1
—
6
50
(3006653) Thiamine [Moles/volume] in Blood
18
112
1.61
1.08
1.2
1.3
nmol/l
145.6
135.5
0.24
18
112
(3027456) Digoxin [Moles/volume] in Serum or Plasma
42
312
1.35
1.08
3.8
3.1
nmol/l
0.8
0.8
0.03
29
235
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
198
1742
1.15
1.07
1.2
1.2
iu/ml
75.8
141.5
4.09
74
645
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
618
5784
1.09
1.07
3.7
3.9
%
22.0
21.9
0.08
291
2619
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
33
2.12
1.05
2.3
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
26
178
1.46
1.05
1.4
1.4
mmol/l
6.4
6.4
0.01
26
161
(3009214) Lutropin [Units/volume] in Serum or Plasma
90
742
1.22
1.04
1.3
1.4
u/l
11.1
9.3
0.59
74
607
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
46
1.96
1.03
2.6
2.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
22
2.27
1.03
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
22
2.27
1.03
1.0
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
22
2.27
1.03
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
114
1.58
1.02
1.2
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
27
381
0.71
1.02
2.6
2.4
%
13.1
13.1
0.17
27
376
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
306
2778
1.11
1.01
1.7
1.7
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
48
1.88
1.00
1.1
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
48
1.88
1.00
1.1
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
48
1.88
1.00
1.1
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
35
2.00
1.00
1.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
27
189
1.43
0.99
1.3
1.1
nmol/l
289.9
379.6
1.19
21
169
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
23
2.18
0.98
2.0
2.3
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
36
1.95
0.97
3.3
5.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
258
1.36
0.96
1.2
1.4
pmol/l
308.9
310.1
0.01
24
204
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
69
1.74
0.96
1.7
2.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
77
1.69
0.95
1.3
1.7
—
—
—
0
0
(4015189)
9
51
1.77
0.94
1.8
2.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
47
364
1.30
0.94
1.4
1.4
u/l
29.4
23.7
0.43
42
297
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
85
1.65
0.94
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
85
1.65
0.94
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
93
1.62
0.93
2.7
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
93
1.62
0.93
2.7
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
93
1.62
0.93
2.7
2.3
—
—
—
0
0
(44806071)
6
27
2.22
0.93
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
35
260
1.35
0.93
1.2
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
28
2.15
0.91
2.0
2.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
28
2.15
0.91
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
78
1.67
0.91
3.8
4.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
26
184
1.42
0.91
1.6
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
38
288
1.32
0.89
1.2
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
6
29
2.07
0.89
1.5
1.3
—
171.3
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
502
1.24
0.88
1.3
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
44
342
1.29
0.87
2.1
1.2
u/l
25.2
38.2
0.55
37
292
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
87
1.61
0.87
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
29
212
1.37
0.86
1.2
1.4
mmol/l
14.3
12.1
—
8
56
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
40
308
1.30
0.85
1.2
1.3
nmol/l
0.6
0.6
0.04
40
295
(40768806) Pleura Pathology biopsy report
28
204
1.38
0.85
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
96
1.57
0.84
1.9
2.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
46
362
1.27
0.84
1.0
1.1
u/ml
2.3
4.9
1.31
25
136
(3037556) Urate [Mass/volume] in Serum or Plasma
10
57
1.76
0.83
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
71
591
1.21
0.80
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
285
1.30
0.80
1.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
176
0.62
0.79
2.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
43
339
1.27
0.78
1.5
1.4
mmol/l
56.1
65.2
1.03
35
268
(3045683) HLA typing for celiac disease panel - Blood or Tissue
22
156
1.41
0.78
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
82
1.59
0.78
4.9
2.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
165
1.40
0.77
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
34
1.77
0.76
1.5
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
28
0.00
0.76
0.0
10.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
53
1.70
0.75
2.1
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
91
1.54
0.75
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
443
4158
1.08
0.74
1.4
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
141
1.42
0.74
1.6
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
147
1308
1.13
0.73
1.4
1.4
iu/l
22.5
28.2
1.77
130
1114
(3035320) C reactive protein [Mass/volume] in Body fluid
21
150
1.40
0.73
3.2
2.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
25
2.00
0.72
2.2
2.8
u/field
0.2
0.8
—
5
25
(3021387) Prolactin [Units/volume] in Serum or Plasma
112
980
1.15
0.72
1.6
1.6
mu/l
274.7
306.4
1.02
106
891
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
211
1.33
0.72
1.6
1.4
e6/l
31588.2
79658.2
0.92
11
132
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
76
1.58
0.71
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
68
572
1.19
0.71
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
41
1.71
0.70
1.1
1.4
—
—
—
0
0
(44806420)
10
61
1.64
0.68
1.9
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
69
1.60
0.68
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
68
575
1.19
0.68
1.4
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
39
313
1.25
0.65
1.2
1.3
nmol/l
—
0.5
—
0
18
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
249
2690
0.92
0.63
4.2
4.1
%
31.8
32.2
0.26
185
1836
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
279
1.26
0.62
1.2
1.3
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
36
289
1.25
0.61
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
139
1.37
0.60
1.6
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
20
148
1.35
0.59
1.2
3.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
210
1.29
0.58
1.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
48
400
1.20
0.58
1.0
1.0
u/ml
2.2
2.9
0.26
24
141
(3039443) Prostate specific Ag panel - Serum or Plasma
45
540
0.83
0.58
1.5
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
86
0.58
0.56
4.4
13.0
—
—
—
0
0
(3020891) Body temperature
93
822
1.14
0.56
9.5
4.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
37
1.62
0.55
1.2
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
31
248
1.25
0.55
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
232
1.25
0.52
1.6
1.4
e6/l
2131.4
2072.3
0.04
18
171
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
53
619
0.85
0.52
1.6
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
40
1.50
0.51
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
55
471
1.17
0.51
1.4
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
41
1.46
0.50
1.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
41
1.46
0.50
1.2
1.6
—
—
—
0
0
(4035726)
221
2060
1.08
0.49
1.4
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
28
226
1.24
0.48
3.1
5.9
mmol/l
6.3
7.4
1.72
21
189
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
33
272
1.22
0.47
3.3
3.5
nmol/l
4.7
6.8
0.48
33
264
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
218
1.24
0.46
2.3
1.9
mg/l
20.0
19.2
—
6
62
(40758292) HTLV I+II Ab panel - Serum
7
49
1.43
0.46
1.3
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
82
0.61
0.45
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
47
546
0.86
0.45
1.9
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
86
1.40
0.44
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
64
564
1.14
0.43
1.1
1.1
u/ml
0.6
1.5
1.18
30
218
(3010726) Horse dander IgE Ab [Units/volume] in Serum
54
470
1.15
0.43
1.1
1.1
u/ml
0.4
2.6
3.36
20
115
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
104
1.35
0.43
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
40
340
1.18
0.43
1.0
1.0
u/ml
0.0
0.4
1.66
15
69
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
158
1.27
0.41
1.5
1.9
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
15.8
—
0
15
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
12.1
—
0
17
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
65
577
1.13
0.40
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
195
1.23
0.40
1.3
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
22
180
1.22
0.36
1.3
1.6
mmol/l
7.0
7.8
1.34
11
108
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
15
117
1.28
0.35
1.3
1.5
—
1743183.3
—
0
9
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
145
1.24
0.33
1.5
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
89
0.67
0.33
1.0
1.1
—
3.9
—
0
14
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
164
1.22
0.32
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
83
760
1.09
0.32
1.5
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
13
101
1.29
0.31
1.9
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
41
464
0.88
0.31
1.5
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
97
897
1.08
0.31
1.9
2.4
—
—
—
0
0
(4133840)
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
47
420
1.12
0.29
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
56
506
1.11
0.29
1.0
1.1
u/ml
10.1
5.2
0.73
31
258
(3029396) Erythrocyte agglutination [Presence] in Blood
7
57
1.23
0.29
3.3
3.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
94
1.28
0.28
1.6
2.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
62
1.29
0.28
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
86
797
1.08
0.27
2.8
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
943
9600
0.97
0.27
2.8
2.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
19
159
1.20
0.26
2.7
3.4
mu/l
19.2
31.1
0.94
19
153
(40768795) Lymph node Pathology biopsy report
25
215
1.16
0.26
1.3
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
11
86
1.28
0.26
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
17
203
0.84
0.25
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
50
550
0.91
0.25
1.3
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
53
483
1.10
0.25
1.0
1.1
u/ml
0.7
1.1
0.68
25
197
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
75
696
1.08
0.24
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
31
274
1.13
0.24
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
75
697
1.08
0.23
1.5
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
36
323
1.12
0.22
2.0
2.2
umol/l
5.1
6.6
0.50
27
241
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
40
1.25
0.22
1.4
2.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
94
0.74
0.22
1.3
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
40
362
1.11
0.22
1.5
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
41
1.22
0.22
1.8
3.4
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
12
98
1.23
0.21
3.1
2.6
mmol/l
8.2
9.3
—
5
73
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
101
0.79
0.21
2.5
1.7
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.2
—
0
6
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
13
0.00
0.21
0.0
6.2
—
7.7
—
0
6
(3018001) Oat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
5
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
1.6
—
0
14
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
260
2681
0.97
0.19
7.8
6.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
74
695
1.07
0.19
1.5
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
120
1147
1.05
0.18
1.8
2.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
37
339
1.09
0.17
1.2
1.3
mmol/l
6.6
7.3
0.73
26
253
(3028707) Methadone [Presence] in Urine by Screen method
53
494
1.07
0.17
2.4
3.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
68
0.73
0.17
1.4
1.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
120
0.83
0.16
1.4
2.7
—
14.8
—
0
12
(4281824)
27
244
1.11
0.16
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
71
1.13
0.16
1.8
2.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
72
1.11
0.16
3.1
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
72
1.11
0.16
6.3
5.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
83
1.21
0.15
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
151
1563
0.96
0.15
1.6
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
44
410
1.07
0.15
1.4
1.4
nmol/l
0.4
0.4
0.19
36
320
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
73
694
1.05
0.14
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
450
1.07
0.14
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
295
3015
0.98
0.14
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
120
1158
1.04
0.13
1.8
2.3
—
—
—
0
0
(4034850)
81
775
1.05
0.13
15.7
8.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
120
1161
1.03
0.12
1.8
2.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
14
124
1.13
0.11
1.2
1.3
mmol/l
45.0
33.3
0.69
14
111
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
39
414
0.94
0.11
3.6
3.8
u/ml
20.5
35.1
1.58
39
403
(3028300) Cannabinoids [Presence] in Urine
120
1166
1.03
0.10
1.8
2.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
45
1.11
0.09
1.6
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
412
0.95
0.09
1.1
1.1
iu/ml
87.8
1410.3
0.51
14
96
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
320
1.06
0.09
1.4
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
110
1070
1.03
0.09
1.9
2.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
88
855
1.03
0.08
1.5
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
127
1.10
0.08
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
205
1.07
0.07
2.1
2.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
235
0.94
0.07
4.2
4.9
u/ml
11.7
77.1
—
8
69
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
172
0.93
0.06
1.1
1.0
u/ml
0.2
0.8
—
8
42
(3018405) Lactate [Moles/volume] in Arterial blood
74
722
1.03
0.05
9.0
3.8
mmol/l
1.4
1.4
0.07
69
710
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
16
149
1.07
0.05
1.3
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
218
1.06
0.05
1.1
1.3
pmol/l
70.8
63.2
—
9
72
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
120
0.92
0.05
1.5
2.1
—
—
—
0
0
(4198724)
12
130
0.92
0.04
1.5
3.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
89
904
0.98
0.03
1.3
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
62
608
1.02
0.03
2.1
1.9
iu/l
4.7
4.6
0.02
21
232
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
106
1047
1.01
0.03
1.7
1.7
mg/l
4.3
3.8
0.21
82
708
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
131
1297
1.01
0.02
1.5
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
16
168
0.95
0.02
1.2
1.1
u/ml
0.3
2.6
—
8
50
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
85
843
1.01
0.01
1.6
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
136
0.96
0.00
1.4
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
154
1.04
0.00
1.2
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
101
1005
1.01
0.00
1.7
1.9
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
204
0.98
0.00
2.1
2.8
mg/l
6.2
33.8
—
10
143
(4146454)
21
208
1.01
0.00
3.1
2.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
126
1258
1.00
0.00
3.6
3.3
u/ml
34.5
50.4
0.77
121
1217
(3015076) Soybean IgE Ab [Units/volume] in Serum
16
157
1.02
0.00
1.1
1.0
u/ml
0.3
3.9
—
5
22
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
3213.3
—
0
5
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
9
98
0.92
0.00
1.0
1.1
—
7.6
—
0
20
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
66
0.91
0.00
1.5
1.5
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
7.6
—
0
6
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
68.8
—
0
5
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
7.4
—
0
7
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
73
0.96
0.00
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
150
1.00
0.00
6.1
6.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
99
0.91
0.00
1.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint RHEUMA_ARHTROPAT_REACTIVE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| RHEUMA_ARHTROPAT_REACTIVE | 1.218 [1.09, 1.37] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.272 |
During the follow-up period (1.1.1998 — 31.12.2019), 938 out of 8775 females with RHEUMA_ARHTROPAT_REACTIVE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| RHEUMA_ARHTROPAT_REACTIVE | 1.248 [1.12, 1.39] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 1291 out of 9100 males with RHEUMA_ARHTROPAT_REACTIVE died.
Mortality risk
Mortality risk for people of age
years, who have RHEUMA_ARHTROPAT_REACTIVE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.105% | 0.27% |
| 5 | 0.792% | 1.373% |
| 10 | 2.003% | 3.698% |
| 15 | 3.651% | 6.94% |
| 20 | 6.399% | 11.844% |
Relationships between endpoints
↥Index endpoint: RHEUMA_ARHTROPAT_REACTIVE – Reactive arthropathies, FINNGEN
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data